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Abstract 
 
Polycomb  group proteins maintain cell identity by repressing developmental 
regulator  genes  specific  for  other  cell  types.  There  are  two  main  complexes: 
Polycomb repressive complex 1 (PRC1) and 2 (PRC2). PRC2 methylates histone H3 
lysine  27  (H3K27me3),  creating  a  binding  site  for  PRC1  that  ubiquitinates 
H2AK119. Polycomb target genes are associated with  stalled  RNA  polymerase  II 
(RNAPII), and the initiation marker H3K4me3, known as bivalent chromatin. Our 
laboratory  has  demonstrated  that  short  RNAs  are  transcribed  from  the  promoter 
region of these genes in human T-cells, while the work carried out as part of the 
present  thesis  demonstrates  that  short  RNAs  are  also  transcribed  in  murine 
embryonic stem cells (ESCs). This indicates that they are conserved across different 
species and cell types. Northern blotting for RNAs ≤200 nucleotides extracted from 
murine ES cell deficient for PRC2 and PRC1 revealed that short RNA production 
is independent of Polycomb activity. When cells differentiate and Polycomb-target 
genes become activated, short RNAs are depleted. Given that PRC2 interacts with 
RNA, this loss of short RNAs might allow gene activation. Additionally, polycomb 
response  elements  (PRE)  have  been  detected  in  Drosophila.  These  elements  are 
necessary  and  sufficient  for  polycomb  recruitment.  A  recently  identified  PRE, 
HOXD11.12,  recruits  PRC2  in  human  mesenchymal  stem  cells  (MSC).  It  is 
hypothesized that PRE activity is due to the transcription of short RNAs. Blotting 
for  RNA  extracted  from  MSC  identified  short  RNAs  transcribed  from  D11.12. 
Moreover,  these  short  RNAs  can  form  the  same  secondary  structure  as  the 
previously-identified short RNAs and are also located at a CpG island. Furthermore, 
RASL12 and YBX2 behave as PREs while D11.12 from active HOXD11 enhances 
gene expression, potentially also acting as a Trithorax response element (TRE).   	 ﾠ 4	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Chapter 1 – Introduction 
 
During  early  development  of  multicellular  organisms  pluripotent  cells 
differentiate into multiple, distinctly(Koontz et al., 2001)  specialized  cells. As every 
cell contains exactly the same genetic information but with different sets of genes 
being  expressed/silenced,  the  process  of  cell  differentiation  requires  meticulous 
regulation  of  gene expression, particularly those that encode for transcription factors 
and  determine  the  anterior-posterior  axis  and  segment  identity  of  metazoan 
organisms. These genes encode proteins with a homeobox domain and are named 
HOX  genes.  It  is  also  fundamental  that HOX  and  other  developmental  genes  are 
maintained  in  the  correct  spatial  and  temporal  expression  pattern  over  multiple 
rounds of mitotic cell division and cell differentiation, which is assured by a set of 
proteins  of  the  polycomb  group.  This  ensures  preservation  of  cell  identity  and 
proper  body  pattern  formation  throughout  the development.  
The study of deregulation in gene orchestration is important, as it is a critical 
pathway  leading  to  diseases  such  as  developmental  disorders  and  cancer. 
Understanding  of  mechanisms  leading  to  such  gene  silencing  or  activation  is  a 
prerequisite for identifying possible ways of counteracting them therapeutically. 
 
1.1 Embryonic development 
Embryonic development starts with cellular division and subsequent and gradual 
specialization of totipotent and pluripotent cells (cells that can become any or nearly 
any cell type, respectively) into cells that perform specific functions (Evans and Hunter, 
2002).  During  embryogenesis,  differentiating  cells  go  through  several  stages  of 
compartmentalization  for  commitment  and  to  perform  specific  functions.  Cellular 
differentiation  involves  meticulous  regulation  and  orchestration  of  expression  of 	 ﾠ 13	 ﾠ
developmental genes, accomplished through communication between neighboring cells 
and their environment. 
Drosophila embryogenesis is followed by three larval stages and pupal stage 
where  metamorphosis  happens  to  form  an  adult  fly.  Mammalian  embryonic 
development, on the other hand, progresses in two major stages: embryogenesis, where 
critical stages for the formation of the embryo happens; and fetal development, where 
the organs of the embryo grow and mature.  
 
1.1.1 Gene regulation in Drosophila embryogenesis 
The first set of transcription factors-encoding genes activated on the onset of 
zygotic transcription is the gap genes, such as the hunchback and Kruppel genes. These 
are  segmentation  genes  and  are  regulated  by  maternal  genes.  Together  they  are 
responsible for the periodic expression of other segmentation genes, pair-rule genes, 
such as paired gene, and the localized expression of several homoeotic genes (Gutjahr 
et al., 1993; Stanojevic et al., 1989). During early embryogenesis, segmentation genes 
establish cellular patterns of gene repression including the Hox genes, which control 
metamerization (Duncan, 1986; Hodgson et al., 1997; Mulholland et al., 2003; Strutt 
and Paro, 1997; Tie et al., 2001). Besides metamerization, segmentation genes are also 
expressed during the development of nervous system (Doe and Scott, 1988; Doe et al., 
1988; Patel et al., 1989). Hox genes are homeotic genes that encode for transcription 
factors (TFs) involved in the development of body structures according to the anterior-
posterior specified body plan containing a homeobox DNA sequence. This box encodes 
for a DNA- or RNA- binding homeodomain. However, not all homeobox-containing 
genes are homeotic, and some segmentation genes also contain a homeobox sequence 
(Gutjahr et al., 1993; Slack, 2012). Hox genes start being expressed at the phylotypic 	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stage and their initial pattern of expression is regulated by the gap and pair-rule genes 
(Bienz and Muller, 1995). In Drosophila melanogaster there are two clusters of Hox 
genes: the Bithorax Complex (BX-C) and the Antennapedia Complex (ANT-C). These 
genes are crucial for the anterior-posterior development in embryogenesis (Faust et al., 
1998; O'Carroll et al., 2001; Pasini et al., 2004).  
 
1.1.2 Mammalian embryogenesis 
The  embryogenesis  in  mammals  has  5  major  stages  (listed  in  order  of 
occurrence): fertilization, cleavage, blastulation, gastrulation and organogenesis (Figure 
1). The process starts with the fertilization of the egg cell (ovum) by a sperm cell, 
(spermatozoon) forming the zygote. Cleavage follows this step with multiple divisions 
of the zygote without growth in volume; thus, each mother cell is divided into daughter 
cells with half of the size. This stage is under maternal effect as protein expression is 
provided by maternal messenger RNA. After four cellular divisions a Morula is formed, 
and at this point, there is the onset of zygotic transcription where the zygote starts 
expressing its own genes. The process continues with the blastulation, where a layer of 
cells surrounding a fluid is formed called the bastula, and it is followed by the formation 
of an inner agglomeration of cells designated ‘inner cell mass’ (ICM) giving rise to a 
blastocyst (the outer layer of cells is trophoblast), and ends with the implantation of the 
embryo. In gastrulation there is cell movement from the inner cell mass of the blastocyst 
to  form  three  germ  layers:  endoderm,  mesoderm,  and  ectoderm.  This  process  is 
accompanied by region specification where cells become committed to the formation of 
an anteriorposterior body plan – phylotypic stage. This gives rise to an embryonic disk 
with a primitive streak, a thickening of the embryonic disk along the median line from 
the rostro to half of the embryo. The embryo is then ready for organogenesis. This stage 
starts with neurulation, and which occurs simultaneously with transversal segmentation 	 ﾠ 15	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of  paraxial  mesoderm.  The  segmentation  gives  origin  to  different  body  parts  from 
which structures derive. There is primitive formation of heart, and then other structures 
follow. (Gutjahr et al., 1993; Slack, 2012). 
 
 
Figure 1: Steps in human embryogenesis. After fertilization there are successive cleavages 
producing a 32-cells Morula, which arrange themselves to produce a cavity called Blastocoel. 
With the formation of the Blastocyst cell specialization begins. The Inner Cell Mass (ICM) gives 
rise to ESCs that will form the three germ layers of the gastrula. 
 
1.2 Cellular differentiation and chromatin 
ESCs are derived from the inner cell mass of the blastocyst. They can 
differentiate into a broad spectrum of cells (pluripotency) and they can propagate 
continuously (self-renewal). OCT4, SOX2, and NANOG are key to the pluripotency of 
ESCs (Avilion et al., 2003; Chambers et al., 2003; Mitsui et al., 2003; Nichols et al., 
1998). OCT4 promotes segregation of ICM and their commitment to the embryonic 
lineage in the pre-implantation embryo, while CDX2 determines trophoblast lineage 
(Nichols et al., 1998; Niwa et al., 2005; Strumpf et al., 2005). Other proteins that are 
chromatin modifiers (better described from the next chapter onwards) also play a role in 
cell fate determination during the pre- and post-implantation embryogenesis.  Examples 
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in the pre-implantation embryo are SETDB1 (SET domain, bifurcated 1; also known as 
ESET and KMT1E), a histone modifier that is crucial for implantation by recruiting 
OCT4 to silence developmental regulators in ICM, which would otherwise become 
trophoblasts, including CDX2 (Bilodeau et al., 2009; Lohmann et al., 2010; Yeap et al., 
2009; Yuan et al., 2009); and Mbd3 (methyl CpG-binding domain protein 3 gene), a 
chromatin remodeller that also upholds ICM development by preventing expression of 
trophoblast-specific genes (Kaji et al., 2007). Other examples include: MOF, which 
directly binds to Nanog, Oct4 and Sox2; and other chromatin modifiers such as TIP60, 
TRRAP (transformation/transcription domain-associated protein), BRG1, and 
SMARCB1 (SWI/SNF-related matrix-associated actin-dependent regulator of 
chromatin subfamily B member 1) (Bultman et al., 2000; Bultman et al., 2006; Ho et 
al., 2009; Kidder et al., 2009; Li et al., 2012; Lohmann et al., 2010; Yeap et al., 2009; 
Yuan et al., 2009).  
Chromatin remodeling has an effect on gene expression and therefore on cellular 
differentiation. In undifferentiated cells, like ESC, chromatin is mostly open, meaning 
that it is accessible to transcription factors and specific modifications that allow 
genomic transcription of both coding and non-coding elements (Efroni et al., 2008). 
Thus, undifferentiated cells are low in heterochromatin, and their chromatin is less 
condensed when compared to differentiated/adult cells. As cells differentiate, global 
chromatin remodelling occurs and exchanges of chromatin proteins are reduced (Ho and 
Crabtree, 2010; Park et al., 2004a). Expectantly, multipotent adult stem cells such as 
hematopoietic stem cells and neural progenitor cells, which occur at low amounts in 
tissues, have an intermediate chromatin state with only a sub-set of ‘stemness’ genes 
active (Schuettengruber et al., 2009). 
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1.3 Chromatin structure and epigenetics 
Chromatin is composed of a long DNA molecule wrapped around histones and 
other bound proteins. There are five types of histone designated H1, H2A, H2B, H3 and 
H4, which are highly conserved among eukaryotes (Szenker et al., 2011).  The simplest 
form of chromatin is a ‘beads-on-a-string’ fiber, each bead being the smallest unit of 
chromatin and designated the nucleosome. 
Chromatin  structure  is  largely  influenced  by  epigenetic  modification, 
modification  caused  by  environmental  factors  that  alter  gene  expression  without 
changes to the DNA sequence and which are heritable, mostly by a processes not fully 
understood. 
 
1.3.1 Chromatin structure 
Chromatin  structure  affects  transcription  (activation  or  repression)  and  other 
processes involving DNA, including replication, DNA repair, and recombination (Li et 
al.,  2007).  Changes  to  chromatin  compaction  by  chromatin  remodelers,  epigenetic 
modifications and histone variants makes DNA accessibility easier or more difficult. 
 
1.3.1.1 The Nucleosome 
The nucleosome is composed of four different histones, a H3/H4 tetramer and 
two H2A/H2B dimers, forming an octamer wrapped by 145-147 base pairs (bp) of DNA 
in a 1.8 helical turn (Figure 2). Chromatinized DNA in the nucleus also contains H1 
bound to the region of exit and entry points of the DNA to the nucleosome. 
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Figure 2: A nucleosome. Eight histone proteins (H4, H3, H2B, H2A) are wrapped around by 
145-147 bp of DNA. H1 keeps DNA wrapped around the octomer.  
 
 
In the genome there are nucleosome-free regions, and other regions with defined 
nucleosomes positions (Jiang and Pugh, 2009; Lee et al., 2007; Yuan et al., 2005). 
Nucleosome assembly on DNA is dependent on DNA sequence and other surrounding 
proteins  (Segal  and  Widom,  2009).  H1  is  more  abundant  in  repressed  loci  than  in 
activated genes (Cockerill, 2011). Nucleosome plus H1 and other proteins form a 10nm 
fibre in vitro. In the presence of 0.5 mM MgCl2 or 60 mM NaCl, this fibre coils for 
further compaction into a 30 nm ‘solenoid’ fibre, but it is unclear if such a structure 
exists  in  cells.  Further  compaction  into  loops  and  rosettes  is  thought  to  form 
chromosomes and this compaction can reach 10,000-fold.  
Nucleosomes  interfere  with  transcription  regulation  through  modifications  on 
histone tails, DNA methylation, variation in histone composition through incorporation 
of  histone  variants  and  through  histone  rearrangement/displacement  by  chromatin 
remodeling  factors,  such  as  histone  chaperones  and  ATP-dependent  chromatin 
remodelers  (Campos  and  Reinberg,  2009;  Kouzarides,  2007;  Li  et  al.,  2007). 
Differences in histone variants include changes in their primary amino-acids sequence 
that can range from a few changes to changes in large domains and they confer different 
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properties  to  the  nucleosome  (Szenker  et  al.,  2011;  Talbert  and  Henikoff,  2010). 
Regarding H3, there are seven variants: H3.1 (mammalian-specific), and H3.2 are both 
canonical thus expressed during S phase where DNA is actively replicating; three H3.3 
variants are associated with actively transcribing chromatin (G1, and G2 phases); and 
there  are  also  the  primate-specific  H3.Y  and  H3.X  (Allshire  and  Karpen,  2008; 
Wiedemann et al., 2010; Witt et al., 1996). Correlating with H3.3 presence at active 
genes, nucleosomes containing this variant are less stable and unable to recruit H1 that 
is involved in chromatin compaction (Braunschweig et al., 2009; Jin and Felsenfeld, 
2007). Histone H2A comprises the canonical H2A (most abundant), the variant H2A.Z 
(vertebrate variants H2A.Z-1 and H2A.Z-2) that confers stability to the nucleosome thus 
avoiding eviction of the H2A/H2B dimer, H2A.X involved in DNA repair, H2A.Bbd 
(H2A.B) associated with active genes during spermatogenesis, and macroH2A (mH2A1 
and mH2A2) ((Bonisch and Hake, 2012; Hoch et al., 2007; Park et al., 2004b; Soboleva 
et al., 2012; Talbert and Henikoff, 2010). Interestingly, when H2A.Z is combined with 
H3.3 the nucleosome becomes more unstable and with higher turnover rates than other 
combination of these histones (Jin and Felsenfeld, 2007). RNA Polymerase II (RNAPII) 
recruits facilitator of active transcription (FACT), which evicts the H2A/H2B dimer 
while RNAPII passes through the nucleosome during transcription; the dimer is then 
replaced after the polymerase has passed (Reinberg and Sims, 2006). 
 
1.3.1.2 Histone modifications 
The  N-terminus  tail  of  histones  is  flexible,  protruding  outwards,  and  can  be 
subjected to posttranslational covalent modifications such as methylation, acetylation, 
ubiquitination,  and  phosphorylation  (Bernstein  et  al.,  2007;  Bonasio  et  al.,  2010; 
Zentner and Henikoff, 2013). Most of these modifications occur on lysines (Lys or K) 
residues  in  the  tails.  Methylation  can  also  occur  on  arginine  (Arg  or  R)  whereas 	 ﾠ 20	 ﾠ
phosphorylation  occurs  on  serines  and  threonines  (Li  et  al.,  2007).  Histone 
posttranslational  modifications  can  lead  to  either  a  permissive  or  repressive 
environment for transcription by causing changes in chromatin structure or by recruiting 
other factors. Histone modifications that promote transcription are acetylation (ac) on 
Lys and Arg residues of histones H3 and H4 (for example H3K27ac) (Margueron and 
Reinberg,  2011),  di-  or  tri-methylation  (me)  of  Lys4  residue  of  H3  (H3K4me2/3), 
H3K36me, H3K79me, and monoubiquitination (ub1) of H2BK123, while modifications 
that are correlated with transcriptional repression are methylation on H3K9, H3K27 and 
H4K20 and ubiquitination (ub) of Lys119 (H2BK119ub) (Kouzarides, 2002; Martin and 
Zhang, 2005; Nguyen and Zhang, 2011; Peterson and Laniel, 2004). Histone acetylation 
directly alters chromatin structure by neutralizing positively charged lysine residues on 
the  histone  tails,  loosening  their  interaction  with  negatively  charged  DNA.  Other 
histone modifications form binding sites for other chromatin regulatory proteins. During 
gene activation, methylation of H3K4 forms a binding site for activator enzymes such 
as acetylases and nucleosome remodelers (Pray-Grant et al., 2005; Santos-Rosa et al., 
2003; Sims et al., 2005; Wysocka et al., 2005). SET domain-containing Trithorax group 
of  proteins  (TrxG)  (described  in  section  1.5),  such  as  the  MLL  group  of  proteins, 
catalyze di- and tri-methylation of H3K4 at transcription start sites (Schuettengruber et 
al., 2011). H3K36me is an elongation mark that locates along the coding regions of 
active genes contrary to H3K27me3 that localizes at promoter regions of silenced genes 
(Mikkelsen et al., 2007). Histone modifications have specific patterns of distribution on 
the  genome  and  many  of  them  are  known  to  be  dynamic  (Bernstein  et  al.,  2007; 
Lanzuolo and Orlando, 2007; Li et al., 2007). 
Histone modifications can be epigenetic. As such, these marks are transmitted 
from  mother  to  daughter  cell  during  mitosis,  thus  keeping  the  gene  in  the  same 
transcriptional state (Margueron and Reinberg, 2010; Probst et al., 2009). Epigenetic 	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modifications are therefore a memory of past stimuli that can be changed in response to 
opposite signals. Whilst epigenetic modifications like H3K9me and DNA methylation 
(a cis modification that occurs on CpG dinucleotides) are well studied and understood, 
the process by which inheritance of H3K4me3, H3K27me3 and other modifications 
happens is not so well understood and require more research on the subject.  
 
1.3.2 Epigenetic modifications 
Two processes are considered to be the basis for epigenetic changes: histone 
modifications and DNA methylation. The links between these two processes is not well 
understood, however it is known that a specific histone methyltransferases can recruit 
DNA methyltransferases to target genes (Vire et al., 2006). Although some epigenetic 
effects can be reversible, X-chromosome inactivation and imprinting are permanent.  
 
1.2.2.1 Methylation of Lysine-27 on H3 
H3K27me2/3  is  a  very  important  and  broad  repressive  histone  mark.  It  is  a 
dynamic modification catalyzed by polycomb repressive complex 2 (PRC2, which is 
better described in chapter 1.4.4) and removed by the demethylases of the Jumonji C 
family: UTX (also named KDM6A), and JMJD3 (also known as KDM6B) (Agger et al., 
2007;  De  Santa  et  al.,  2007;  Hong  et  al.,  2007).  UTX,  unlike  JMJD3,  contains  a 
tetratricopeptide  motif  for  which  predictions  indicate  functions  in  protein-protein 
interactions, and it is mainly enriched at promoter compared to protein-coding regions 
(Agger et al., 2007). Both demethylases regulate HOX gene clusters. 
H3K27me3 is present in 15% of the H3 proteins in mammalian ESCs (Peters et 
al., 2003). In the fruit fly and mammals, the CREB-binding protein (CBP)-mediated 
histone mark H3K27ac is believed to antagonize H3K27 methylation and is enriched in 	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its absence (Tie et al., 2009). A few studies (Azuara et al., 2006; Francis et al., 2009; 
Hansen et al., 2008; Margueron et al., 2009) have given glimpses of how H3K27me3 
might be preserved through DNA replication. Once H3K27me3 is established, PRC2 
binds to it at the G1 phase of cell division, and this is sufficient for both the recruitment 
of the three core subunits of this complex and to direct H3K27me3 on the new daughter 
strand during DNA replication. PcG can physically be maintained on the chromatin 
during replication in vitro (Francis et al., 2009).  
 
1.2.2.2 DNA methylation 
DNA methylation is a known epigenetic modification that happens on position 5 
of cytosines (5mC) of the dinucleotide CpG palindrome. It causes gene silencing when 
located on a transcription start site (TSS) but stimulates transcription and may even 
influence  splicing  when  located  in  the  gene  body  (Jones,  2012).  It  occurs  in  most 
animals; exceptions being, for instance, the nematode worm Caenorhabditis elegans 
that has no methylation and the fruit fly Drosophila melanogaster that rather methylates 
CpT dinucleotides at a low percentage. On the other hand, vertebrates account for the 
group of animals with highest amount of methylated CpG (Bird, 2002), they have over 
85% of CpG sites methylated. Another phenomenon is the occurrence of CpG islands, 
DNA  regions  with  200  base  pair  or  more  that  are  CpG-rich  (ten  times  higher  than 
average  in  the  genome)  that  associate  with  60%  of  promoters,  including  all  of  the 
housekeeping genes and half of tissue specific genes (Antequera and Bird, 1993; Larsen 
et al., 1992). Only less than 10% of these regions are permanently methylated (Bergman 
and Cedar, 2013; Bird, 2002). An example of this is X-chromosome inactivation and 
genomic  imprinting.  5mC  is  also  important  for  chromosome  stability  by  repressing 
repeated regions such as centromeres allowing proper chromosome segregation during 
mitosis,  and  by  repressing  transposable  elements  (Moarefi  and  Chedin,  2011).  CpG 	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island origin has been suggested to result from the deoxyribonucleic triphosphate pool 
present at a determined time-frame window of S phase (Cross et al., 1991). However 
this factor might contribute, if this were the only factor, C:G incorporation would occur 
along  the  entire  body  of  the  gene  rather  than  enriched  at  the  5’end  and  promoter. 
Another suggestion comes from the fact that replication initiation sites co-localize with 
CpG islands and have different properties of transcription elongation, being possible 
that their components could render difficult the access of enzymes that catalyze DNA 
methylation  (Antequera,  2003;  Antequera  and  Bird,  1999).  Maintainance  of  DNA 
methylation  is  accomplished  by  the  three  DNA  methyltransferases  (DNMT3a, 
DNMT3b  and  DNMT1).  De  novo  DNA  methylation  is  mediated  by  DNMT3a, 
DNMT3b whereas DNMT1 uses as substrate hemimethylated DNA duplex to include a 
methylation  diagonally  on  the  new  strand,  a  process  important  for  example  in 
imprinting (Wood and Oakey, 2006). De novo methylation by DNMT3a at intergenic or 
non-promoter-proximal regions also has the capability of inhibiting silencing by PcG in 
neurogenic genes being fundamental for neurogenesis (Wu et al., 2010). 
 
1.4 Polycomb 
1.4.1 The discovery of polycomb group proteins in Drosophila 
Polycomb (Pc) is a gene first identified in the fruit fly Drosophila melanogaster 
in 1947 by P. Lewis for its essential role in maintaining Hox genes in a repressed state 
as concluded from random mutagenesis screens and observation of their phenotypic 
effects (Breen and Duncan, 1986; Duncan, 1982; Gaytan de Ayala Alonso et al., 2007; 
Jurgens et al., 1971; Lewis, 1978; Paro and Hogness, 1991; Struhl and Akam, 1985). 
This way, like Pc, a number of other genes were identified and therefore designated 
polycomb group proteins (PcG) (Breen and Duncan, 1986; Duncan, 1982; Grimaud et 
al., 2006b; Jurgens et al., 1971; Lewis, 1978; Sato and Denell, 1985; Struhl and Akam, 	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1985). PcG proteins are involved in regulation of gene expression by keeping genes 
repressed  that  were  initially  regulated  by  segmentation  genes.  The  expression  of 
segmentation genes fades, and Hox genes are then kept repressed by polycomb group 
(PcG) proteins. PcG proteins do not only silence Hox genes. The first indication of this 
phenomenon came in 1989 where it was observed that the Pc protein also binds to PcG 
genes (Zink and Paro, 1989). Later genomic distribution including genome-wide studies 
of  PcG  proteins  distribution  revealed  they  occupy  genes  encoding  for  transcription 
regulators  involved  in  development  and  responsible  for  cell  differentiation  (e.g. 
neurogenesis),  morphogenesis,  and  signalling  pathway  both  in  flies  and  mammals 
(Boyer et al., 2006; Bracken et al., 2006; Lee et al., 2006; Negre et al., 2006; Schwartz 
et  al.,  2006;  Squazzo  et  al.,  2006;  Tolhuis  et  al.,  2006).  The  expression  of  some 
polycomb proteins becomes barely detectable at the end of embryogenesis (Gutjahr et 
al.,  1995).  Polycomb-mediated  silencing  is  conserved  from  plants  to  humans,  thus 
reflecting  the  importance  of  this  mechanism  (Birve  et  al.,  2001;  Cao  et  al.,  2002; 
Czermin et al., 2002; Franke et al., 1992; Kuzmichev et al., 2002; Levine et al., 2002; 
Ross and Zarkower, 2003; Schumacher and Magnuson, 1997; Shao et al., 1999; Simon 
and Kingston, 2013; Tie et al., 2001).  
PcG proteins are found in the form of multi-subunit complexes. There are five 
identified polycomb complexes in Drosophila: Polycomb repressive complex 1 (PRC1), 
PRC2,  Pho-Repressive  Complex  (PhoRC),  dRING-associated  factors  (dRAF)  and 
Polycomb Repressive Deubiquitinase (PR-DUB) (Francis et al., 2004; Lanzuolo and 
Orlando, 2012). With the exception of dRAF all their components have orthologues in 
mammals (Klymenko et al., 2006; Lanzuolo and Orlando, 2012; Scheuermann et al., 
2010;  Schuettengruber  and  Cavalli,  2010;  Simon  and  Kingston,  2009).  The  first 
indication that PcG proteins form complexes was in Drosophila from the observation 
made  by  co-immunoprecipitation  showing  that  the  proteins  polycomb  (Pc), 
polyhomeotic  (Ph)  and  posterior  sex  comb  (Psc),  which  all  belong  to  PRC1,  co-	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precipitate (DeCamillis et al., 1992; Franke et al., 1992). Similar observations were 
made  for  Esc  and  E(z)  (belonging  to  PRC2)  and  further  biochemical  purifications 
confirmed the existence of two separate complexes (Jones et al., 1998; Shao et al., 
1999; Tie et al., 1998). 
 
1.4.2 Polycomb group proteins in mammals 
Genome-wide  chromatin  immunoprecipitation  (ChIP-Chip)  analysis  in  mouse 
and human ESCs (Boyer et al., 2006; Lee et al., 2006) showed that PRC proteins bind to 
homeodomain-encoding  genes  of  transcriptional  regulators  -  Hox  genes  –  that  are 
involved  in  anterior-posterior  development,  as  well  as  other  developmental  genes. 
Mammals have four clusters of HOX genes: HOX A, B, C, and D; each localised on 
different chromosomes.  Studies show that PRC proteins also bind to cell cycle and 
proliferation  genes  (Negre  et  al.,  2006;  Oktaba  et  al.,  2008;  Schwartz  et  al.,  2006; 
Squazzo et al., 2006), and genes encoding components of signal transduction pathways 
such as Wingless and Notch (Janody et al., 2004; Tolhuis et al., 2006). Other processes 
where PcG have been involved include X-inactivation (Silva et al., 2003; Wutz, 2011; 
Zhao et al., 2008), genomic imprinting (Martinez and Cavalli, 2006; Terranova et al., 
2008; Wolff et al., 2011), senescence (Aguilo et al., 2011; Bracken et al., 2007; Jacobs 
et  al.,  1999),  cancer  (Simon  and  Lange,  2008),  cell  reprogramming  (Pereira  et  al., 
2010),  and  immunity  through  maintenance  of  thymic  epithelium  (Liu  et  al.,  2013), 
lymphopoiesis in B-cell development (Su et al., 2003), and in controlling CD4+ T-cells 
differentiation  into  T  helper  1  (Th1)  and  Th2  (Tumes  et  al.,  2013).  The  many 
implications of this group of proteins show their importance for a variety of treatments 
that can be reflected on cancer, tissue regeneration and the induction of pluripotent stem 
cells. 
 	 ﾠ 26	 ﾠ
1.4.3 The PRC1 Complex 
PcG  proteins  are  conserved  from  flies  to  humans  (Levine  et  al.,  2002).  In 
mammals, there are two main complexes of polycomb proteins - PRC1 and PRC2 – 
with  a  higher  number  of  homologues  and  isoforms    (from  16  different  genes  in 
Drosophila  to  37  in  mice  and  humans)  that  can  result  in  molecular  redundancy 
(Whitcomb et al., 2007).  
 
Table 1: Polycomb group complexes and its respective subunits. Based on Lanzuolo and Orlando (2012) 
Drosophila  Mammals 
Polycomb repressive complex 1 (PRC1) 
Ph  HPH1-3 
Psc  PCGF1-6 
Pc  CBX2-8 
dRybp  RYBP, YAF2 
Sce  Ring1A-B 
Polycomb repressive complex 2 (PRC2) 
E(z)  EZH1, EZH2 
Su(z)12  SUZ12 
Esc  EED 
Nurf55  RbAp46/48 
Jarid2  JARID2 
Jing  AEBP2 
Pcl  PCL1-3 
Pho repressive complex (PhoRC)   
Pho  YY1 
dSfmbt  SFMBT1 
Polycomb repressive deubiquitinase (PR-DUB) 
Calypso  BAP1 
ASX  ASXL1 	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PRC1 is composed of six groups of subunits (Table 1). The components of this 
complex  and  respective  Drosophila/mammalian  orthologues  are:  Ph/HPH1-3 
(polycomb-like  protein);  Pcs/  PCGF1-6;  Pc/CBX  family  (Polycomb  Chromobox 
protein);  Sce  (Sex  comb  extra)/RING1A/B  and  dRybp/RYBP  (Ring1/YY1-binding 
factor) and YY1-associated factor 2 (YAF2) homologues (Francis et al., 2001; Lanzuolo 
and Orlando, 2012; Levine et al., 2002; Simon and Kingston, 2009). PCGFs (PcG ring 
fingers) group is constituted by the paralogues NSPC1 (nervous system Pc1)/PCGF1, 
MEL18/PCGF2, PCGF3, BMI1/PCGF4, PCGF5, MBLR (Mel18 and Bmi1-like ring 
finger)/PCGF6.  Each  paralogue  has  been  identified  to  be  part  of  a  distinct  PRC1, 
forming six different complexes, PRC1.1-PRC1.6. In particular, PRC1.2 and PRC1.4 
can form two sub-complexes of unique subunit composition, one that contains CBX and 
HPH, and another that rather contains RYBP/YAF2. These two sets of subunits are 
mutually exclusive as they compete for binding to RING1B. This non-CBX-containing 
PRC1 or RYBP-PRC1 is designated non-canonical or variant PRC1 (Gao et al., 2012). 
RYBP-PRC1 contains other associated proteins such as L3MBTL2 or KDM2b (Farcas 
et al., 2012; He et al., 2013; Qin et al., 2012; Trojer et al., 2011; Wu et al., 2013). RYBP 
and YAF2 are homologues and mutually exclusive too.  
 
Figure 3: PRC1 complex. Representation of canonical (PRC1.1-PRC1.6) and non-canonical 
PRC1 complex (PRC1.2 and PRC1.4). Canonical and non-canonical PRC1.2 and PRC1.4 are 
mutually exclusive. 
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1.3.3.1 PRC1-mediated gene repression 
RING1A/B, an ubiquitin E3 ligase, promotes the mono-ubiquitination of histone 
H2A at lysine 119 (H2AK119ub1) (Bentley et al., 2011; Brown et al., 1998; Cao et al., 
2005;  Kallin  et  al.,  2009;  Wang  et  al.,  2004a).  Reports  show  that  H2A  mono-
ubiquitination by PRC1 contributes to gene silencing by blocking RNAPII elongation in 
ESCs (Brookes et al., 2012; Stock et al., 2007; Zhou et al., 2008), concordant with 
studies showing that PRC1 and RNAPII co-localize at target genes (Breiling et al., 
2001;  Dellino  et  al.,  2004;  Min  et  al.,  2011).  If  H2AK119ub1  is  lost,  even  though 
H3K27me3 is present, repression is also lost (Bernstein et al., 2006a; de Napoles et al., 
2004;  Wang  et  al.,  2004a).  It  has  also  been  shown  experimentally  that  this  gene 
silencing mark is heritable (de Napoles et al., 2004). H2AK119ub1 co-localises with 
H3K4me3 at a higher percentage than H3K27me3, 97% to 79% (Brookes et al., 2012). 
Blocking  RNAPII  transcriptional  elongation  is  not  the  only  way  of  PRC1 
repressiveness.  Indeed,  PRC1  silences  target  genes  through  various  mechanisms:  it 
inhibits ATP-dependent chromatin remodelling of the hSWI/SNF complex, and induces 
chromatin  compaction  in  a  manner  that  requires  nucleosomes  but  not  histone 
modifications such as H2AK119ub1 since it can be accomplished in tail-less histones 
(Eskeland et al., 2010; Francis et al., 2004; King et al., 2005; Margueron et al., 2008; 
Shao et al., 1999). Psc (Polycomb sex comb), a Drosophila ortholog of human PCGF1-
6, is the main subunit part of the PRC1 core components responsible for this type of 
repression, since mutation in this subunit but not in dRING1 cause gene activation. 
However, loss of ubiquitination through mutation of Ring1 leads to complete loss of 
repressive  activity  at  some  other  genes  (Gutierrez  et  al.,  2012).  PRC1  also  recruits 
histone deacetylases (HDACs) (Tie et al., 2001; van der Vlag and Otte, 1999). The 
diverse  PRC1  complexes  occupy  distinct  genomic  loci  but  their  target  genes  show 	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similar enrichments of gene ontology (GO) terms (Gao et al., 2012). PRC1 contains a 
single unit of each subgroup of the complex, and they are interdependent of one another 
for  gene  repression  (Maertens  et  al.,  2009).  Nonetheless,  orthologs  can  co-localize 
through the binding of multiple PRC1 complexes simultaneously (Maertens et al., 2009; 
Pemberton et al., 2014). 
 
1.4.4 The PRC2 complex 
PRC2 is composed of four core subunits, where the catalytic component is the 
SET domain of the subunit enhancer of zeste  homologue  2 (EZH2) (Cao et al., 2002; 
Czermin et al., 2002; Kuzmichev et al., 2002), which is conserved from flies to humans. 
The other three core subunits are suppressor of Zeste 12 (SUZ12), embryonic ectoderm 
development  (EED), and Retinoblastoma-associated proteins 46 and 48  (RbAp46/48; 
also  known  as  RBBP7/4;  and  Nurf55  in  Drosophila)  (Cao  and  Zhang,  2004a; 
Margueron  and  Reinberg,  2011;  Nowak  et  al.,  2011)  and  each  is  relevant  for  the 
functionality  of  the  complex.  Non-stoichiometric  subunits  of  PRC2  are  adipocyte 
enhancer-binding protein 2 AEBP2 (Peng et al., 2009), JARID2 (Chen et al., 2011; 
Landeira et al., 2010; Pasini et al., 2010; Peng et al., 2009), and PHF1 (PCL1), PHF19 
(PCL3), MTF2 (PCL2) which are the mammalian orthologs for the fruit fly polycomb-
like (Pcl) protein (Margueron and Reinberg, 2011; Simon, 2010). HDACs, although not 
part  of  PRC2,  also  interact  with  this  complex.  JARID2  (jumonji  (jmj)  AT-rich 
interactive  domain  (ARID)  2)  belongs  to  jmj  family  of  proteins,  whilst  AEBP2 
(adipocyte enhancer binding protein 2) is a zinc finger protein (He et al., 1999; Kim et 
al., 2009), evolutionarily well conserved from flies to mammals (Kim et al., 2009) that 
is  present  in  murine  brain  tissue,  which  has  been  shown  to  co-purify  with  the 
mammalian PRC2 (Cao et al., 2002; Cao and Zhang, 2004a, b) and shares the same 
target loci (Kim et al., 2009).  	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1.4.4.1 PRC2-mediated gene repression 
PRC2 is firstly recruited to its genomic site to catalyse methylation of H3K27 
(Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; Muller et al., 2002). 
The SET domain of EZH2 is required for recruitment to target genes (Margueron et al., 
2008) while EED and SUZ12 are necessary for the enzymatic activity of EZH2 (Cao 
and Zhang, 2004b; Montgomery et al., 2005; Pasini et al., 2004) . Esc (EED ortologue) 
binds directly to histone H3 and this binding is necessary for the catalytic activity, 
which  indicates  that  PRC2  interacts  with  chromatin  through  histones  rather  than 
binding  directly  to  DNA  (Tie  et  al.,  2007).  Similarly,  mammalian  EED  binds 
H3K27me3, suggesting a mechanism by which this histone mark may be propagated 
(Margueron et al., 2009). EED may also function in PRC2 repressive activity through 
its interaction with HDACs (van der Vlag and Otte, 1999). 
The  PRC2  component  EZH2  has  a  variant  paralogue,  EZH1,  which  might 
confer  different  properties  to  the  complex  and  these  two  paralogs  are  mutually 
exclusive in the complex (Margueron et al., 2008). EZH1 can replace EZH2 in PRC2 
and  is  particularly  predominant  in  adult  non-dividing  cells,  and  is  capable  of 
polynucleosome compaction. EZH2 is highly expressed during embryogenesis and in 
proliferating  cells.  Complexes  containing  EZH2  have  higher  HMT  activity  than 
EZH1-containing complexes (Bracken et al., 2003; Margueron et al., 2008; Shen et 
al., 2008). Although EZH1 methylates H3K27 weakly, it mediates gene repression 
mainly  through  chromatin  compaction  accomplished  through  binding  to  a  few 
nucleosomes and bringing them together (Margueron et al., 2008). Still, EZH1 seems 
to complement EZH2 in maintaining stem cell identity (Shen et al., 2008). Another 
function  related  with  transcriptional  activation  as  also  been  reported  for  EZH1 
(Mousavi et al., 2012; Stojic et al., 2011). The H3K27me3 mark enables condensation 	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of  chromatin  and  inhibition  of  chromatin  remodelling,  facilitated  probably  by 
providing a binding site for PRC1 (Cao et al., 2002; Czermin et al., 2002; Francis et 
al., 2001; Kirmizis et al., 2004; Kuzmichev et al., 2002; Muller et al., 2002; Shao et 
al., 1999).  
There  are  also  four  distinct  isoforms  of  EED  due  to  alternative  translational 
starting sites. PRC2 has been categorized as the form of the complex containing the 
largest isoform, EED-1, and can assist methylation of both H3K27 and H1K26, whereas 
complexes containing the shortest isoforms, EED-3 and EED-4, named PRC3, can only 
methylate H3K27 (Kuzmichev et al., 2004). The EED-2 isoform is expressed only in 
cancer  and  undifferentiated  ES  cells,  and  is  part  of  another  complex,  PRC4,  which 
preferentially methylates H1 (Kuzmichev et al., 2005). 
JARID2 has essential roles in tissue development and has been identified as a 
transcriptional repressor with demethylase activity (Takeuchi et al., 2006). JARID2, like 
other PcG proteins, is also required for the differentiation of mouse ESCs (Pasini et al., 
2010). The jmjC domain is a characteristic feature of the jmj family of H3K27-specific 
demethylases but due to amino-acids substitutions it is inactive in JARID2 (Cloos et al., 
2008; Swigut and Wysocka, 2007). The ARID domain, present in JARID2, binds to 
DNA specially enriched for CG and GA dinucleotides, but is not present in every jmj 
protein. JARID2 binds to more than 90% of previously mapped PcG target genes and is 
sufficient to recruit PcG proteins (Landeira et al., 2010; Li et al., 2010; Pasini et al., 
2010; Peng et al., 2009; Shen et al., 2009). This recruitment and tethering of PRC2 is 
dependent on the ARID domain DNA-binding ability (Kim et al., 2003; Li et al., 2010; 
Pasini et al., 2010; Peng et al., 2009). There are reports saying that JARID2 inhibits 
HMT activity of PRC2 (Peng et al., 2009; Zhang et al., 2011), and controversially, other 
reports show that it rather stimulates HMTase activity (Li et al., 2010; Mejetta et al., 
2011).  It  is  rather  possible  that  JARID2  fine-tunes  the  H3K27me3  level  in  vivo  as 	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suggested by Shen et al (2009). JARID2 can bind to DNA potentially through its ARID 
domain,  thus  facilitating  anchoring  of  PRC2;  ChIP-Seq  shows  a  significant  binding 
overlap between the two (Landeira et al., 2010; Li et al., 2010; Pasini et al., 2010; Peng 
et  al.,  2009;  Shen  et  al.,  2009).  JARID2  inhibition  leads  to  loss  but  not  complete 
abolition of PcG binding and a subsequent reduction of H3K27me3 and H2AK119ub 
levels on target genes (Landeira et al., 2010; Li et al., 2010; Shen et al., 2009). Besides 
the ARID domain, JARID2 contains a C5HC2 zinc finger and both may synergize to 
bind to DNA (Kim et al., 2004; Kim et al., 2003; Li et al., 2010). Landeira et al. (2010) 
further shows that the presence of Ser 5 phosphorylated RNAPII correlates with the 
presence of JARID2, implying that JARID2 is required for the poised state of PRC 
engaged genes and subsequent reactivation. 
There are 3 PCL proteins, which bind to subsets of PRC2 binding sites and are 
also involved in PcG recruitment (Aloia et al., 2013; Brien et al., 2012; Hunkapiller et 
al., 2012; Walker et al., 2010). PHF19 (PCL3) binds to H3K36me3 through its Tudor 
domain  also  recruiting  the  H3K36me3  demethylase  NO66  (Brien  et  al.,  2012). 
Knockdown  of  PHF19  results  in  reduction  of  both  H3K27me3  and  SUZ12  binding 
(Hunkapiller et al., 2012). In Drosophila, it is required for high levels of H3K27me3 but 
not  H3K27me1  and  H3K27me2  (Nekrasov  et  al.,  2007).  RbAp46/48  (PRC2)  are 
histone-binding proteins that are also present in HDAC and co-repressor complexes 
(Cao et al., 2002; Kuzmichev et al., 2002). 
 
1.4.5 Canonical and noncanonical PcG gene repression 
In  canonical  PcG  repression,  PRC1  and  PRC2  often  co-occupy  target  sites 
(Boyer et al., 2006; Ku et al., 2008; Schwartz et al., 2006). PRC2 is firstly recruited to 
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H3K27me3  through  the  CBX  chromodomain,  which  recognizes  this  modification. 
Therefore, H3K27me3 functions as a docking site for PRC1 recruitment and targeting 
(Figure 3) (Cao et al., 2002; Fischle et al., 2003; Min et al., 2003). In murine ESCs, 
CBX7 is probably the main recruiter of PRC1 as it is more predominant in these cells. 
However,  as  cells  differentiate,  CBX7  fades  and  only  a  subset  of  canonical  PRC1 
(CBX2-  and  CBX4-containing  PRC1)  prevails,  as  they  are  fundamental  for  proper 
differentiation (Aloia et al., 2013; Gao et al., 2012). 
Noncanonical  PRC1  is  a  variant  that  does  not  contain  CBX  or  PHC  and  is 
composed of one PCGF paralog, RYBP and RING1A/B. RYBP and CBX are mutually 
exclusive  (Gao  et  al.,  2012;  Kalenik  et  al.,  1997).  This  means  that  a  different 
recruitment mechanism of PRC1 must exist that is independent of PRC2. RYBP binds 
to RING1B through its C-terminal domain and this is important for its functionality by 
enhancing H2AK119 ubiquitination independently of PRC2 (Gao et al., 2012; Tavares 
et  al.,  2012)  Recent  work  in  mouse  ESCs  also  indicates  that  RYBP-PRC1  can  be 
recruited independently of PRC2 to unmethylated CpG islands via KDM2b (Farcas et 
al.,  2012;  He  et  al.,  2013;  Wu  et  al.,  2013).  RYBP-PRC1  and  CBX7-PRC1  target 
overlapping genomic sites, being the genes bound by both the most repressed (Morey et 
al., 2013). Additionally, RYBP has been demonstrated to possess repressive activity, by 
binding to YY1 and possibly establishing a link between YY1 and PcG (Garcia et al., 
1999). 
Concordant with different mechanisms of PRC1 silencing, PRC1 and PRC2 can 
bind genomic sites independently of each other’s action (Ku et al., 2008; Richly et al., 
2010; Sing et al., 2009; Trojer et al., 2011). Due to this independent binding of PRC1 
and PRC2, questions regarding the role of H3K27me3 have been raised.  Supporting 
recruitment  of  PRC1  independently  of  H3K27me3,  there  is  a  low  abundance  of 
H3K27me3 (Nekrasov et al., 2007) at the core of PRE regions whereas PC is highly 	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enriched,  and  that  H3K27me3  occupies  broad  domains  whereas  PC  rather  occupies 
narrow regions (Papp and Muller, 2006; Schwartz et al., 2006). Furthermore, after the 
absence of the lysine tri-methylation, the loss of PRC1 is gradual (Ohno et al., 2008). 
Not only recruitment of PRC1 can be independent of H3K27me3 as PRC1-dependent 
H2AK119ub1  leads  to  PRC2  recruitment  and  subsequent  H3K27  trimethylation 
(Blackledge  et  al.,  2014).  Additionally,  and  as  mentioned  above  in  section  1.2.2.1, 
H3K27me3 can recruit PRC2 (Hansen et al., 2008). Histone variants also play a role in 
polycomb targeting.  Histone H3.3 is required for higher rates of histone turnover and 
has been demonstrated to be involved in the establishment of H3K27me3 via promoting 
interaction of its histone chaperone with PRC2 (Banaszynski et al., 2013). 
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Figure  4:  Representation  of  the  canonical  mechanism  of  polycomb  mediated  gene 
repression.  PRC2  is  recruited  to  the  genomic  site,  trimethylates  H3K27,  which  servesas  a 
binding site for PRC1. RING1B, the catalytic subunit of PRC1 the monoubiquitanates H2AK119, 
which cause RNAPII to stall. 
 
1.4.6 Other PcG complexes 
Biochemical purification of pleiohomeotic (Pho) revealed that it forms a third 
PcG complex in Drosophila, known as Pho repressive complex (PhoRC) (Klymenko et 
al., 2006).  This complex is composed of Pho, pleiohomeotic-like (Phol) and SCM-
related gene containing four MBT domains (dSfmbt). The transcription factor yin yang-
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1 (YY1) has been described as the mammalian homolog of Pho (Brown et al., 1998; 
Klymenko  et  al.,  2006;  Wang  et  al.,  2004a);  it  is  conserved  between  vertebrates 
(Pisaneschi et al., 1994; Shi et al., 1991); and is ubiquitous. While it is known that Pho 
and Pho-like proteins are important for polycomb repressiveness in Drosophila, the role 
of YY1 in mammals is not clear (Atchison et al., 2003; Srinivasan and Atchison, 2004). 
 
1.5 Trithorax group proteins 
Trithorax group proteins (TrxG) are counterparts of the PcG proteins that also 
maintain gene expression patterns through epigenetic modifications (Maeda and Karch, 
2006; Ringrose and Paro, 2004), but act antagonistically to them (Moehrle and Paro, 
1994). They have long-term effects in Drosophila Hox genes but there is no certainty of 
such  effect  in  vertebrates  (Maeda  and  Karch,  2006;  Ringrose  and  Paro,  2004). 
Expression of the genes regulated by the PcG-TrxG system are fine tuned and dynamic 
along  the  development  (Ringrose,  2007),  this  being  essential  for  embryonic 
development and cell differentiation (Christophersen and Helin, 2010; Schumacher and 
Magnuson, 1997) and stem cells and differentiated cells identity by binding to essential 
developmental  regulators,  cell  growth  and  proliferation  factors  (Mendenhall  and 
Bernstein, 2008; Ringrose and Paro, 2004; Ringrose et al., 2003). Like PcG, they are 
conserved across species (Ringrose and Paro, 2004; Schuettengruber et al., 2007). 
Proteins of the Trithorax group act in multimeric complexes that can be divided 
in  two  groups:  1)  SET  domain-containing  histone  methyltransferases;  2)  ATP-
dependent chromatin-remodelling factors. Some other TrxG proteins can bind to DNA 
and act as chromatin remodelers and histone modifiers (Schuettengruber et al., 2011). 
Complexes of the first group include COMPASS that catalyses the trimethylation of 
H3K4 (Wu et al., 2008); COMPASS-like (MLL1-2 in one complex and MLL2-4 in 	 ﾠ 36	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another  complex)  that  has  tumor  suppressor  activity  (Yang  and  Hua,  2007)  and 
catalyses of the acetylation of H4K16 (Gu et al., 1992). The demethylase UTX also 
belongs to the COMPASS-like complex, which removes H3K27me3 mediated by PRC2 
(Agger et al., 2007); and ASH1 that has methyltransferase acivity for H3K36. To the 
second group belong SWI/SNF that binds to acetylated histones via its bromodomain 
(part  of  Brahma;  BRM  and  BRG1)  (Chatterjee  et  al.,  2011);  ISWI  that  recognizes 
H3K4me3  via  its  PHD  finger  (Wysocka  et  al.,  2006);  and  CHD1-8  that  bind  to 
H3K4me3  and  have  histone  deacetylase  activity  (Gaspar-Maia  et  al.,  2009; 
Schuettengruber et al., 2011). 
Studying of the mechanisms underlying Trx function can open new doors to cell 
regeneration,  longevity  and  environmental  stresses  as  well  as  possibly  other  venues 
(Greer et al., 2011; Klebes et al., 2005; Siebold et al., 2010). 
 
1.6 Genomic profiling of polycomb function  
PcG proteins, known gene repressors, have some targeted genes that have low to 
high levels of activity (Brookes et al., 2012; Nishiyama et al., 2009; Tolhuis et al., 
2006;  Young  et  al.,  2011).  However,  this  might  be  due  to  allelic  differences  in 
expression where one allele is expressed and the other one is silent (Brookes et al., 
2012); this is possibly to be the case of imprinted genes. 20% of silent genes do not 
show ChIP-seq signal for H3K27me3, PRC1 or 2, nor RNAPII. From the same study 
(Brookes et al., 2012), PRC-target silent genes may show the presence of H3K27me3 
only (no RNAPII present), which mainly happens in differentiated cells (with signalling 
and stimuli genes) where developmental regulators specific to other cell types have to 
be  maintained  in  a  silent  state  to  maintain  cell  identity;  or  presence  of  both  PRCs 	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deposited marks plus RNAPII, which occur more on developmental and metabolism-
related genes important for embryogenesis.  
 
1.6.1 Bivalency 
Numerous promoters of mammalian developmental genes are associated with bivalent 
chromatin,  a  term  coined  by  Bernstein  et  al.  (2006a)  because  it  contains  two 
antagonistic  histone  marks:  H3K27me3,  a  marker  for  gene  repression,  and  tri-
methylation  at  H3K4,  a  marker  of  transcription  initiation  present  in  active  genes 
(Azuara et al., 2006; Bernstein et al., 2006a). Bivalent genes are silent but some show a 
low level of expression (Brookes et al., 2012; Voigt et al., 2013). Bivalent domains are 
dominant at the pre-implantation stage and are a common feature of ESC (Alder et al., 
2010) but not of the Drosophila epigenome (Schuettengruber et al., 2009). Bivalency 
occurs in different cell types in mammalian species, including humans (Pan et al., 2007; 
Voigt et al., 2013; Zhao et al., 2007), and other vertebrates too (Vastenhouw et al., 
2010). Bivalency is a particular signature of ESCs where mouse and human bivalency 
largely overlap (Voigt et al., 2013). Bivalent marks co-exist in the same nucleosome 
(Voigt et al., 2012), although not in the same histone (Voigt et al., 2012; Young et al., 
2009), meaning that they are not a result of cell heterogeneity. To further support this 
conclusion, a study (Marks et al., 2012) took advantage of 2i medium (that functions by 
inhibiting both Erk signaling and glycogen kinase 3 (Ying et al., 2008), thus preserving 
the naive state of ESC by keeping the expression of lineage-specific genes at a lower 
level and thus preserving cellular homogeneity (Nichols and Smith, 2009)), to culture 
ESC  and  still  found  bivalent  domains,  although  fewer  in  number.  Bernstein  et al. 
(2006a) studied bivalent domains in highly conserved noncoding elements (HCNEs), 
which are mostly present at genes that encode for TFs such as Hox and Sox, Fox and 	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Pax  gene  families  (Bernstein  et  al.,  2006a).  Especially  the  regulatory  regions  of 
vertebrate Hox clusters contain HCNEs in and around the genes existing around 200 of 
these loci (Bejerano et al., 2004; Lindblad-Toh et al., 2005; Woolfe et al., 2005). 75% 
of H3K27me3 domains (5 kb) in HCNEs are also methylated on K4 where 50% of these 
are present at TFs genes (Bernstein et al., 2006a; Lee et al., 2006). In a broader genomic 
study, Mikkelsen et al. (2007) identified three different classes of promoter according to 
CpG  content.  99%  of  CpG-high  promoters  –  promoters  of  housekeeping  genes  or 
developmental  genes  –  were  enriched  for  H3K4me3,  22%  of  which  were  bivalent. 
There is therefore a correlation between CpG islands, bivalency and conserved regions.  
Upon  cell  differentiation,  most  bivalent  domains  resolve  into  monovalent 
H3K27me3 (some of which become DNA methylated) (Mohn et al., 2008), H3K4me3 
or  neither  mark  (Mikkelsen  et  al.,  2007).  Nonetheless,  many  new  bivalent  sites  are 
formed  in  progenitor  stem  cells  that  also  have  a  ESC-like  prevalence  of  bivalent 
domains, as it is the case in neural progenitor cells (NPC), mesenchymal stem cells 
(MSC), hematopoietic stem cell (HSC), showing this is a highly dynamic process (Cui 
et al., 2009; Mikkelsen et al., 2007; Mohn et al., 2008; Paige et al., 2012). Bivalency 
occurs in cultured ESCs as in the inner cells of the blastocyst of the developing embryo 
(Rugg-Gunn et al., 2010). In the trophoblast and extra-embryonic endoderm stem cells, 
H3K9me3 replaces H3K27me3 mark and function as bivalent marks (Rugg-Gunn et al., 
2010). 
It is also worthy to note that bivalency can also happen with the repressive mark 
H2Aub1, which blocks RNAPII transcription, where 97% of the marks coincide with 
H3K4me3 whereas 79% of H3K27me3 overlaps H3K4me3. The three marks can co-
exist (Brookes et al., 2012). 
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1.6.2 Elongation by RNAPII and transcriptional pausing 
Production of mRNA starts with the assembly of a pre-initiation complex (PIC) 
together with general transcription factors (GTFs) and a mediator complex, being these 
recruited to gene promoter. It was initially thought that blocking such recruitment was 
the only way of regulating gene expression. However, it was found that regulation could 
happen  at  the  level  of  elongation  too  (Figure  4).    Promoter-proximal  pausing,  first 
identified in Drosophila heat shock promoters, for example HSP70 (Gilmour and Lis, 
1986;  Rougvie  and  Lis,  1988),  is  associated  with  transcripts  of  around  20-60 
nucleotides (nt) (Rasmussen and Lis, 1993; Rougvie and Lis, 1988). Other ground-
breaking examples of such studied genes are HIV TAR, from which transcripts of 59-nt 
are produced from the HIV LTR in unstimulated cells (Kao et al., 1987); and MYC 
(Bentley and Groudine, 1986). In these three cases, pausing is due to the action of two 
factors:    DRB  sensitivity-inducing  factor  (DSIF)  and  negative  elongation  factor 
(NELF).  The  repressive  activity  is  antagonized  by  the  recruitment  of  positive 
transcription  elongation  factor  (P-TEFb)  (Marshall  and  Price,  1992).  Subsequent 
genome-wide  studies  demonstrated  that  this  type  of  transcriptional  regulation  is  a 
common feature in Drosophila and mammalian genomes too (Guenther et al., 2007; 
Nechaev and Adelman, 2008; Price, 2008; Zeitlinger et al., 2007), probably to allow 
rapid and efficient expression upon physiological changes.  
The ends of the integrated HIV provirus comprise a long terminal repeat (LTR) 
segmented  into  U3,  R,  and  U5  (Knipe,  2006).  In  naïve  resting  CD4  T-cells  the 
provirus is in a latent state but transcription is still initiated, producing a short RNA 
named TAR (trans-activation response element). TAR is a cis RNA required for the 
activation  of  the  provirus  through  binding  of  the  viral  Tat  (trans-activator  of 
transcription)  protein,  which  occurs  when  T-cells  encounter  an  antigen  and  are 	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activated. A significant feature of the TAR RNA is its stem-loop secondary structure 
that is required for Tat binding (Feng and Holland, 1988). Initiation of transcription 
takes place at the U3/R border of the 5’LTR but in the absence of Tat transcription is 
aborted about +55 to +59 downstream of TSS and RNAPII stalls (Kao et al., 1987). 
At HIV, as well as in cellular genes, RNAPII phosphorylated at Ser5 but not Ser2 
stalls downstream of the TSS (Yamaguchi et al., 2013). Activation of transcriptional 
elongation occurs after recruitment of the elongation factor P-TEFb, in the HIV case 
by Tat. The CDK9 subunit of P-TEFb phosphorylates RNA polymerase II Ser2 (Kim 
et al., 2002) as well as NELF and the DSIF subunit Spt5 causing them to dislodge 
(Fujinaga et al., 2004; Ivanov et al., 2000). Additionally, EZH2 has been linked to the 
HIV LTR (Friedman et al., 2011), which was found tri-methylated at H3K27 and 
ubiquitinated on H2A (Kim et al., 2011). Knockdown of EZH2 leads to reactivation of 
the provirus (Friedman et al., 2011).  
Pausing can also happen further into productive elongation (Adelman and Lis, 
2012; Brookes et al., 2012). Such genes, for example Lhx5, Pitx1, and Zfp503, show 
higher expression levels upon de-repression than genes where RNAPII is paused near 
the TSS, such as Fgf5, Kcnc4, and Lrat (Brookes et al., 2012). Consistent with the 
presence  of  a  transcription  initiation  marker  (H3K4me3)  at  polycomb-target  genes, 
RNAPII  is  recruited  to  the  promoter,  starts  transcription,  but  stalls  and  ceases 
productive elongation (Chopra et al., 2009; Dellino et al., 2004; Stock et al., 2007). 
RNAPII is present at a substantial percentage of H3K27me3-associated silent genes 
from Drosophila to humans (Guenther et al., 2007; Muse et al., 2007; Zeitlinger et al., 
2007). At perichromatic regions, border regions of condensed chromatin, transcription 
is mainly paused and this region is also rich in polycomb proteins (Cmarko et al., 1999; 
Ruthenburg et al., 2007; Shahbazian and Grunstein, 2007; Trentani et al., 2003). 	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The largest subunit of RNAPII, RPB1, contains a Carboxy-terminal domain 
(CTD) that comprises the heptapeptide consensus sequence N-Tyr1-Ser2-Pro3-Thr4-
Ser5-Pro6-Ser7-C  repeated  26  times  in  yeast,  42  in  Drosophila  and  52  times  in 
mammals.  The  residues  in  this  sequence  are  subjected  to  post-translational 
modification, particularly the phosphorylation of Serine (Ser) residues (Patturajan et 
al.,  1998).  RNAPII  can  be  unphosphorylated,  Ser5  phosphorylated  (S5P),  and 
hyperphosphorylated  (S5P  +  S2P).  Phosphorylation  of  Ser  5  is  essential  for 
transcription  initiation,  capping  and  recruitment  of  Lys4  methyltransferases;  while 
escape from the pause position, transcription elongation, polyadenylation, splicing and 
recruitment of Lys36 HMT require phosphorylation at Ser 2 (Brookes et al., 2012; 
Cadena and Dahmus, 1987; Sims and Reinberg, 2004). Therefore, paused RNAPII is 
phosphorylated only at Ser5 at bivalent genes that are silent, and have no H3K36me3; 
however S5P can also be found on coding regions at low levels (Brookes et al., 2012). 
PRC genes are mainly S5P, and hyperphosphorylated RNAPII is not detected above 
background levels (Brookes et al., 2012; Stock et al., 2007). Such polycomb active 
genes encode for transcription factors involved in ESC identity such as Hmga2, Klf4 
and Tbx3. Levels of Nanog, a ESC mark of pluripotency, influences whether PcG 
target  genes  are  expressed  or  not.  RNAPII  stalling  at  PcG  target  genes  has  been 
attributed to the H2AK119ub1 modification by PRC1 (Brookes et al., 2012; Stock et 
al., 2007). 
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Figure  5:  Gene  transcription;  A  –  Silent  genes:  transcription  is  inhibited  at  the  level  of 
initiation  where  the  recruitment  of  RNAPII  to  the  promoter  is  inhibited;  Gene  site  is  highly 
methylated  on  H3K27.  B  –  Silent  gene:  transcription  is  inhibited  at  the  level  of  elongation. 
RNAPII is phosphorylated at Serine-5 only and the promoter is methylated both at H3K27 and 
H3K4. C – Gene is expressed: RNAPII is phophorylated at both Serine-5 and -2; promoter is 
methylated at H3K4 only and the body of the gene is trimethylated at H3K36. 
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1.7 Polycomb recruitment to chromatin 
1.7.1 Polycomb Responsive Elements in flies  
Polycomb  responsive  elements  (PREs)  are  cis-regulatory  sequences  initially 
identified in transgenic Drosophila embryos and larvae that confer polycomb repressive 
activity (Muller and Bienz, 1991; Simon et al., 1993), thus recruiting PRC1 and PRC2 
complexes (Oktaba et al., 2008).  Identification of PREs has proven difficult given the 
lack of identifiable sequence homology. Using algorithms based on several aspects that 
seem relevant to Drosophila PREs, quite accurate predictions have been attained for this 
animal model. Unfortunately, it has been harder to find it in mammals where only three 
PRE sequences have been identified so far.  	 ﾠ 43	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PREs of the Drosophila Hox clusters, like the bithoraxoid PRE, can be located 
thousands of base pairs away, 20-30 kb, from the transcription start site (Chan et al., 
1994; Sengupta et al., 2004), whereas PREs like engrailed (Kassis, 1994) and many 
other Drosophila PREs are located close to the transcription start sites (Bloyer et al., 
2003; Schwartz et al., 2006). 
In Drosophila, PcG proteins interact with chromatin by binding to Pho and Pho-
like proteins (Brown et al., 1998; Wang et al., 2004a). Genome-wide binding profile of 
PhoRC, PRC1, and PRC2 shows that the three complexes co-localise on a large set of 
genomic  sites,  identified  as  PREs,  and  that  Pho  not  only  directly  interacts  with  Pc 
(PRC1)  and  Esc/E(z)  (PRC2)  but  it  is  also  required  for  the  recruitment  of  both 
complexes (Oktaba et al., 2008; Schwartz et al., 2006; Wang et al., 2004a). But, little is 
known regarding the regulation of Pho binding to PREs. It is likely that the carboxy-
terminal binding protein (CtBP) interacts with Pho in its recruitment as analysis of the 
PREs scr and engrailed in wild-type and mutated Drosophila embryos revealed that 
loss of this protein results in an increased expression of intergenic transcripts and in a 
reduced binding of Pho (Basu and Atchison, 2010). A binding site of 17bp has been 
identified for Pho (Brown et al., 1998), with a consensus sequence of only four base 
pairs, CCAT, considered the core binding site of Pho (Ringrose et al., 2003). 
Pho/Phol alone are not sufficient to recruit PcG complexes in vitro (Brown et al., 
2003; Dejardin et al., 2005), and Pho/Phol double mutants don’t generally interfere with 
PcG binding in polytene chromosomes (Brown et al., 2003; Wang et al., 2004b). Other 
DNA-binding proteins must be important for PRE functionality and many have been 
identified in Drosophila. These proteins include GAGA factor (GAF: also known as 
TRL), pipsqueak (Psq), zeste, dorsal switch protein 1 (Dsp1), grainyhead (GH) and 
specificity protein 1 (SP1) or Luna (also known as KLF) (Simon and Kingston, 2009). 
In an attempt to predict PREs on a large scale, Ringrose and colleagues designed an 	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alignment-independent algorithm that searches for one or more possible motifs for each 
of the proteins GAF, Psq, zeste and Pho/Phol. They found that clustered pairs rather 
than single cluster motif were required to distinguish between Drosophila PREs and 
non-PREs (Ringrose and Paro, 2007; Ringrose et al., 2003). Another study suggested 
that although Gaf, Zeste and Pho sites are necessary, they are not sufficient to make a 
PRE  (Dejardin  et  al.,  2005).  Taking  this  into  consideration,  Rehmsmeier  and  co-
workers constructed another prediction algorithm by incorporating the Dsp1, GH, and 
Sp1/KLF sites, and including comparative genomic data from four Drosophila genomes 
it improved the overlapping of predicted PREs with published polycomb ChIP data 
from 20% to 34% (Hauenschild et al., 2008). Recently, it has been shown that Dsp1 is 
important for PcG recruitment given that abolishment of Dsp1 binding to certain PREs 
causes  loss  of  PcG  proteins  binding,  thus  showing  relevance  in  their  recruitment 
(Dejardin  et  al.,  2005;  Wang  et  al.,  2010).  None  of  these  proteins,  however,  are 
considered part of the polycomb group since mutations do not lead to PcG phenotype 
(Schuettengruber et al., 2009). 
Genetic  evidence  demonstrates  that  Drosophila  PREs  also  function  as  TREs 
(Trithorax response element), as these sequences are bound by both TrxG and PcG 
proteins (Chan et al., 1994; Orlando et al., 1998; Papp and Muller, 2006; Tillib et al., 
1999) and supported by the existence of bivalency at PcG-target sites (Schuettengruber 
et al., 2009). Trithorax group (TrxG) proteins are required for active gene transcription 
(Ringrose and Paro, 2004). They include the proteins Trithorax (Trx) and Ash1 (absent, 
small, or homeotic discs 1), two SET domain-containing proteins that methylate H3K4 
(Klymenko and Muller, 2004). An example is the bithorax Fab-7 PRE/TRE, which is 
capable of recruiting PcG proteins as well as acting as a TRE that can maintain the 
memory  of  active  chromatin  states  during  embryogenesis  (Cavalli  and  Paro,  1999; 
Klymenko  and  Muller,  2004).  The  relative  levels  of  PcG,  and  Trx  at  target  genes 	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determine the chromatin state, thus creating a delicate and dynamic balance (Schwartz 
et al., 2010). Interestingly, the PRE binding proteins Zeste, Gaf and Pipsqueak also 
appear to have an activatory function (Decoville et al., 2001; Hagstrom et al., 1997; 
Huang et al., 2002). 
 
1.7.2 Polycomb Responsive Elements in mammals 
Although  much  has  been  investigated  about  PRE/TREs  in  Drosophila,  in 
mammals, PREs are not well defined. PRE-kr (Kreisler), is the first mammalian PRE to 
be identified (Sing et al., 2009). It is 3kb long and regulates expression of the mouse 
MafB/Kreisler gene. PRE-kr was capable of causing repression of a reporter gene in a 
PcG-dependent manner and both PRC1 and 2 complexes can bind the PRE sequence, 
albeit PRC2 binding is weak, which suggests different binding requirements. Although 
prediction algorithms did not identify the PRE-kr, it contains a 450-bp highly conserved 
region between human, mouse and chicken, and the consensus Pho/YY1-binding sites 
and GAGAG motifs (Sing et al., 2009). 
Another mammalianPRE, identified in the human Hox cluster between the genes 
HOXD11 and HOXD12, is designated HOXD11.12 (Woo et al., 2010). It is 1.8 kb long, 
is enriched for both H3K4me3 and H3K27me3, has a highly conserved sequence of 
237-bp,  and  contains  GC-rich  sequences.  Characteristics  consistent  with  Drosophila 
PREs include YY1 binding sites, nucleosome depletion and repression by PcG protein 
maintained throughout differentiation. Woo et al. (2010) showed that deletion of the 
YY1 binding motif and especially the highly conserved region, as well as interaction 
with the protein RYBP, all interfere with PRE repressive ability and especially PRC1 
binding. 
Common  characteristics  of  these  two  PREs  are:  regions  of  high  sequence 	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conservation  (Lee  et  al.,  2006),  and  GC-rich  sequences  (Ku  et  al.,  2008).  GC-rich 
regions are preferentially bound by PcG (Lynch et al., 2012), and seem to be sufficient 
to  recruit  PRC2  (Mendenhall  et  al.,  2010).  Other  characteristics  of  PREs  include 
nuclease-hypersensitivity, revealing nucleosome depletion at these sites (common with 
Drosophila PREs) (Mohd-Sarip et al., 2006; Muller and Kassis, 2006; Papp and Muller, 
2006), and chromatin flanking a PRE sequence that contains nucleosomes marked with 
H3K27me3 (Pan et al., 2007; Schwartz et al., 2006). 
 
1.6.3 The involvement of YY1 
YY1 is a multifunctional protein (Bushmeyer et al., 1995) that performs roles 
in DNA repair (Wu et al., 2007) and transcription regulation, capable of acting as both 
an  activator  (Cai  et  al.,  2007;  He  et  al.,  2010;  Seto  et  al.,  1991)  and  a  repressor 
(Atchison et al., 2003) of genes, due to the possession of distinct domains (Bushmeyer 
et al., 1995). Its effect on the silencing of transcription can be accomplished through 
multiple  mechanisms  (Galvin  and  Shi,  1997;  Guo  et  al.,  1995),  for  example,  by 
interacting with transcription factor LSF to inhibit the expression of HIV-1 provirus – 
a mechanism not well understood (Romerio et al., 1997).  
Pho, YY1, and Phol are all sequence-specific DNA binding proteins that contain 
related zinc finger DNA-binding domains (Brown et al., 2003; Brown et al., 1998). 
YY1  interacts  with  the  protein  RYBP,  which  in  turn  interacts  with  the  PRC1 
components  RING1A,  RING1B,  and  M33/CBX2.  YY1  has  also  been  reported  to 
interact with the PRC2 and PRC1 subunits EED and BMI1 respectively (Caretti et al., 
2004;  Satijn  et  al.,  2001).  Conversely,  another  report  indicates  that  YY1  does  not 
interact with PRC2 (Li et al., 2010). The discrepancy of these results might be due to 
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YY1  is  the  mammalian  homolog  of  Pho  and  HMGB2  is  the  mammalian 
homolog of Dsp1 (Gabellini et al., 2002). Krüppel-related zinc-finger protein/T-helper-
inducing POZ/Krüppel-like factor (cKrox/Th-POK) is the vertebrate orthologue to the 
Drosophila Gaf, and are linked to PcG recruitment (Matharu et al., 2010). While it is 
known that Pho and Phol are important for Polycomb repressiveness in Drosophila, the 
role of YY1 in mammals is not fully clear. The observation that the consensus binding 
sequences of Pho and YY1 have a perfect match suggests that YY1 is a PcG protein. 
(Brown et al., 1998). Studies in Drosophila show that YY1 recruits (Caretti et al., 2004) 
and interacts with PcG proteins, like EED (Atchison et al., 2003; Palacios et al., 2010; 
Satijn  et  al.,  2001;  Srinivasan  and  Atchison,  2004),  and  Pho  also  interacts  and  co-
localises with both PRC1 and PRC2 (Klymenko et al., 2006; Mohd-Sarip et al., 2002; 
Oktaba  et  al.,  2008;  Wang  et  al.,  2011).  Nonetheless,  a  study  in  mouse  ESC  has 
evidenced that YY1 does not interact (Vella et al., 2012) nor co-localise with PRC2 
(Squazzo et al., 2006). Among other observations that YY1 might constitute a PcG 
protein that its binding sites are present and required for the four known mammalian 
polycomb  responsive  elements:    PRE-kr,  HOXD11.12,  HOXC11.12  and  HOXB4.5 
(Woo et al., 2010, 2013). It functionally compensates for Pho in Drosophila (Atchison 
et al., 2003; Srinivasan et al., 2005), YY1 is a developmental gene regulator essential 
for  embryogenesis  and  tissue  formation  (Donohoe  et  al.,  1999;  He  et  al.,  2007). 
However, YY1 distribution does not correlate with PcG genome-wide (Squazzo et al., 
2006), but it is possible that YY1 is implicated in PRC recruitment for a specific set of 
genes  only,  what  would  reflect  the  variety  of  mechanisms  involved  (Simon  and 
Kingston, 2013). 
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1.7.4 Other potential mammalian recruiters 
Proteins such as JARID2, AEBP2, and PCL may act to tether PcG to chromatin 
(Casanova et al., 2011; da Rocha et al., 2014; Kim et al., 2009; Landeira et al., 2010; 
Nekrasov et al., 2007). Tet1 was found to demethylate DNA at CpG islands in mouse 
(Tan and Shi, 2012) and is also important for PRC2 binding to chromatin and both 
PRC2 and Tet1 co-localise at more than 95% of target sites (Wu et al., 2011). SNAIL is 
another protein that interacts with EZH2 and SUZ12, at the E-cadherin gene of mouse 
ESCs (Herranz et al., 2008). Runx1/CBFb recruits PRC1 in a subset of PcG targets in a 
PRC2-dependent manner (Yu et al., 2012). REST is required for the recruitment of both 
complexes in a sub-fraction of Pc-regulated neural genes (Dietrich et al., 2012). Other 
proposed proteins are NurD (Reynolds et al., 2012), and PLZF (Barna et al., 2002). 
Despite PRE binding proteins being mostly absent in vertebrates, prominent features of 
PcG proteins are their association with promoter regions, bivalent domains, CpG-rich 
promoters, high sequence conservation, and also with ncRNAs. 
A  new  consensus  in  the  field  is  that  CpG  islands  are  involved  in  polycomb 
recruitment. Introduction of CpG island or GC-rich DNA into the genome of mESCs is 
sufficient for PRC2 binding, suggesting that PRC2 is recruited to these sites (Ku et al., 
2008; Mendenhall et al., 2010). However, CpG islands that are associated with activator 
factors  or  that  are  DNA  methylated  do  not  recruit  PRC2  (Lynch  et  al.,  2012; 
Mendenhall et al., 2010).  
Recent studies (Blackledge et al., 2014; Cooper et al., 2014; Kalb et al., 2014) 
have shown that PRC2 and H3K27me3 can also form and be recruited by the variant 
PRC1 through H2AK119ub1. PRC2 subunits that bind to this modification are JARID2 
and  AEBP2,  which  subsequently  stimulate  H3K27me3  (Kalb  et  al.,  2014).  Loss  of 
H2AK119ub1 leads to subsequent loss of PRC2 and H3K27me3 occupancy genome-
wide. Variant PRC1 is probably recruited to CpG islands through recognition of non-	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methylated  CpG  by  the  CXXC-zinc  finger  domain  of  KDM2B  (Blackledge  et  al., 
2014). It was also demonstrated that hypomethylated CpG islands are in fact sufficient 
to  recruit  PRC1  and  PRC2  and  that  PcG  recruitment  is  default  to  these  regions; 
counteraction of polycomb recruitment at these sites is accomplished by histone H3 tail 
modifications (Cooper et al., 2014). 
  
 
1.8  The  role  of  polycomb  in  ESC  pluripotency,  differentiation 
and development  
ESCs  are  derived  from  the  inner  cell  mass  of  the  blastocyst.  They  can 
differentiate  into  a  broad  spectrum  of  cells  (pluripotency)  and  they  can  propagate 
continuously (self-renewal). OCT4, SOX2, and NANOG are key to the pluripotency of 
ESCs (Avilion et al., 2003; Chambers et al., 2003; Mitsui et al., 2003; Nichols et al., 
1998) and they co-localise with PRC2 at developmental genes (Boyer et al., 2005; Lee 
et  al.,  2006).  PcG  function  is  particularly  relevant  in  neural,  hematopoietic  and 
epidermal stem cell proliferation, self-renewal and differentiation (Aloia et al., 2013; 
Mohn et al., 2008; Molofsky et al., 2003).  
It is fundamental that Hox and other developmental genes are coordinated in a 
correct  spatial  and  temporal  expression  pattern  over  multiple  rounds  of  mitotic  cell 
division and differentiation, thus ensuring a correct formation of the body structure. 
Genome-wide  analyses  have  revealed  that  PcG  proteins  are  highly  enriched  at  the 
promoter region of hundreds of developmental regulators in ESC that would otherwise 
induce cell differentiation (Azuara et al., 2006; Boyer et al., 2006; Lee et al., 2006; 
Mikkelsen et al., 2007; Negre et al., 2006). Hence, genes necessary for a specific cell 
type are expressed while unnecessary genes are repressed. ESCs have been highly used 	 ﾠ 50	 ﾠ
for  the  study  of  polycomb  group  proteins  given  the  relevance  of  these  proteins  in 
pluripotency and differentiation. 
During  embryogenesis,  PcG  proteins  regulate  anterior-posterior  development 
(Simon et al., 1992). Mutations lead to ectopic expression of developmental genes and 
therefore to segment defects. Mutations in Eed, Ezh2, Suz12, Rybp and Ring1b (not 
Ring1A), even cause lethality by gastrulation arrest (Alkema et al., 1995). Knockout of 
Ring1B leads to premature differentiation of neural stem cells (Roman-Trufero et al., 
2009),  and  knockouts  of  Jarid2  and  Kdm2b  cause  improper  neural  development 
(Fukuda et al., 2011; Takeuchi et al., 1995). Mel18 or Bmi1 deficiency causes anterior-
posterior  defects  at  the  axial  skeleton  plus  immune  deficiency,  while  simultaneous 
mutation of both components cause lethality (Akasaka et al., 1996; Alkema et al., 1995; 
van der Lugt et al., 1994).  
 
1.9 Polycomb disregulation in cancer 
Mutations  as  well  as  alterations  in  epigenetic  modifications  can  result  in 
repression of tumor suppressors or genomic stabilizer genes and lead to the formation of 
carcinogenic cells (Benetatos et al., 2013; Bracken and Helin, 2009; Richly et al., 2011).  
Deregulation of PcG protein expression, particularly EZH2 overexpression or 
gain  of  function  is  correlated  with  progression  of  several  types  of  cancer  including 
prostate,  lymphoma,  breast,  melanoma,  bladder,  gastric,  and  renal  cancers  and  also 
correlated  with  poor  prognostic  (Simon  and  Lange,  2008;  Velichutina  et  al.,  2010). 
EZH2  is  particularly  important  as  it  silences  the  expression  of  over  200  tumor 
suppressors (Simon and Lange, 2008). EZH2 harbor several heterozygous mutations at 
the tyrosine 641 of the C-terminal SET domain, which do not correlate with loss of 
function  but  rather  an  enhancement  of  function  of  H3K27me2  on  its  substrate 	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(Sneeringer  et  al.,  2010;  Yap  et  al.,  2011)  and  are  found  in  a  low  but  significant 
percentage  on  a  two  different  types  of  lymphomas  (Morin  et  al.,  2010).  Another 
mutation found at a lower percentage in lymphoma cell lines is Alanine to Glycine 
mutation on position 677 of the EZH2 protein that has an enhancement of function as 
the previous described mutation but acts on H3K27, H3K27me1, and H3K27me2. 
Glioblastoma is an aggressive form of cancer, with a high mortality rate, that 
arises  from  astrocytes  and  which  accounts  for  20%  of  all  brain  tumors  in  children 
(Saran, 2002).  A frequent mutation in the glioblastoma tissue occurs in histone H3.3, 
which is incorporated during brain development, and consists of a replacement of lysine 
27  by  methionine  (K27M).  H3  Lysine  27  amino-acid  is  a  common  site  for  histone 
modifications such as the referred methylation and acetylation. Therefore, mutation at 
this  position  can  lead  to  alteration  in  gene  expression,  in  a  way  by  inhibiting  the 
enzymatic  activity  of  PRC2  (Khuong-Quang  et  al.,  2012;  Lewis  et  al.,  2013; 
Schwartzentruber et al., 2012). 
In all types of endometrial stromal tumors (EST) the zinc fingers of SUZ12 and 
JAZF1 are fused. Such fusion occurs in stromal nodules too indicating that stromal 
proliferation from an initially benign tumor can develop into EST (Koontz et al., 2001). 
Also JAZF1-PCL1 fusions in ESTs. EZH2 also cooperates with other histone modifiers 
such as DNMTs (Vire et al., 2006), and HDAC (Tie et al., 2001; van der Vlag and Otte, 
1999), which are found and linked to various types of cancer. Sites that are marked by 
H3K27me3 may become CpG methylated; DNA methylation sites are, to some extent, 
also marked by H3K27me3 and EZH2 (Fahrner et al., 2002; McGarvey et al., 2006; 
McGarvey  et  al.,  2008).  PRC1  has  also  been  linked  to  cancer  given  that 
medulloblastoma cells overexpress BMI1 (Leung et al., 2004). 	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Targeting  PcG  proteins  can  be  a  strategy  to  reduce  metastasis  and  increase 
effectiveness of chemotherapeutic drugs (Bracken and Helin, 2009; Crea et al., 2011; 
Croonquist  and  Van  Ness,  2005;  Kemp  et  al.,  2012;  Varambally  et  al.,  2002).  An 
example of a drug that depletes cellular levels of PRC2 core components and associated 
H3K27me3  is  S-adenosylhomocysteine  hydrolase  inhibitor  3-Deazaneplanocin  A 
(DZNep).  This  drug  has  low  in  vivo  cytotoxicity  (Bray  et  al.,  2000),  and  induces 
apoptosis of cancer cells leaving normal cells alive (Tan et al., 2007). Another potential 
group  of  therapeutic  drugs  constitutes  S-adenosyl-L-methionine  (SAM)-  competitive 
inhibitors as the SET domain contains a pocket for a SAM methyl donor (Copeland et 
al.,  2009).  It  will  be  a  clinical  challenge  to  develop  combined  drugs  to  target 
methyltransferases (for histone and DNA) as well as HDACs. 
 
 
1.10 Non-coding RNAs 
Only around 2% of the mammalian genome is transcribed into coding messenger 
RNA (mRNA), and at least 90% of transcribed RNA is non-coding (ncRNA) (Bertone 
et al., 2004; Birney et al., 2007; Cheng et al., 2005; Djebali et al., 2012; Kapranov et al., 
2002; Rinn et al., 2003), which means that it is not translated into proteins, giving rise 
to thousands of transcripts, most of which are uncharacterized. This phenomenon is 
known as ‘pervasive transcription’ and has been described in most eukaryotic organisms 
(Berretta and Morillon, 2009) (Mercer et al., 2009), with the transcriptome of human 
ESCs comprising around 10
5-5x10
4 transcripts (Brockdorff, 2013).  
Comparing the amount of ncRNA with the amount of genes (~20,000-25,000) 
between  organisms  suggests  that  rather  ncRNA  may  be  critically  important  for 
determining the complexity of eukaryotes (Costa, 2010). Concordant with their wide 
variety, they have a myriad of functions many of which are regulatory at different levels 	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(transcription,  post-transcriptional  processing,  and  regulators  of  protein  activity) 
(Britten  and  Davidson,  1969;  Geisler  and  Coller,  2013;  Jacob  and  Monod,  1961). 
ncRNA  can  be  divided  into  small  ncRNA  (sRNA),  smaller  than  200  nt,  and  long 
ncRNA (lncRNA), longer than 200 nt. The diverse types of ncRNA include ribosomal 
RNA (rRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), small nucleolar 
ncRNA  (snoRNA),  micro  RNA  (miRNA),  small  interfering  RNA  (siRNA),  piwi-
interacting RNA (piRNA), and long non-coding RNA such as long intergenic RNA 
(lincRNA)  and  others.  The  former  three  types  of  RNA  mentioned  above  can  be 
described as classical non-coding RNAs. In eukaryotes about 80% of all RNA is rRNA; 
tRNA makes up 15% whereas mRNA accounts for only 5% (Warner, 1999). Lin-4 
miRNA (Lee et al., 1993; Wightman et al., 1993), and XIST (Borsani et al., 1991; 
Brockdorff et al., 1992; Brown et al., 1992) were the first non-classical ncRNAs with 
assigned functions. 
 
1.10.1 ‘Housekeeping’ ncRNAs – rRNA, tRNA, snRNA  
The central dogma of molecular biology views the existence of three types of 
RNA involved in protein synthesis: the mRNA, which is a copy of the DNA blueprint 
for the amino-acid sequence; the rRNA which forms a ribonucleoprotein complex of 
two subunits, called the ribosome, that bind together during mRNA translation; and the 
tRNA that transports the amino-acids to the ribosomes. Sequences of rRNA genes are 
highly conserved.  There are four different types of rRNA in eukaryotes designated 28S, 
18S, and 5.8S that result from the cleavage of a single long precursor (pre-rRNA), and 
5S that is transcribed from a separate gene and is not processed extensively. In the 
nucleolus, pre-rRNA assembles with ribosomal proteins that are imported from pre-
ribosomal particles. With the exception of 5S precursor rRNA, rRNA is cleaved twice, 
firstly to form 18S and 28S + 5.8S, then secondly to form the three different rRNAs. 	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Cleavage  of  pre-rRNA  is  accomplished  by  a  complex  of  proteins  with  snoRNA  (a 
subgroup of snRNA) that form small nucleolar riboprotein complex (snoRNPs). RNAPI 
transcribes this pre-rRNA from a single promoter in the nucleolus whilst 5S rRNA, 
together with tRNA and snRNA, is transcribed by RNAPIII in the nucleus. tRNA, like 
rRNA, is also processed by cleavage of pre-tRNA at the 3’ and 5’ ends by two different 
ribozymes. CCA sequence is then added to the 3’ end and some bases are modified. 
snRNAs range in size from 50-200 nt. snRNAs, particularly the U-type snRNAs (U1, 
U2,  U5,  and  U4/U6),  are  important  regulatory  molecules  involved  in  pre-mRNA 
splicing. Splicing takes place in large complexes, called spliceosomes, composed of 
these snRNAs and proteins to form small nuclear ribonucleoproteins (snRNPs). For the 
splicing process, firstly U1 binds the 5’splice site (SS) consensus sequence of the pre-
mRNA, followed by U2 binding to the branch consensus sequence point. The branch 
corresponds to a point where the 5’SS becomes ligated to the intron. Then a complex 
formed by U4/U6 and U5 joins the spliceosome as U1 is released and a lariat-like 
structure  is  formed  with  U5  binding  the  3’  SS  and  causing  excision  of  the  intron 
(Cooper, 2000). 
 
1.10.2 MicroRNA and siRNA 
MicroRNAs (miRNAs) belong to a class of non-coding RNAs that have a post-
transcriptional gene expression regulatory function. miRNAs are single stranded RNAs 
(ssRNA)  approximately  19-25  nucleotides  in  length  and  were  first  identified  in  the 
nematode C. elegans (Kim, 2005; Lee et al., 1993; Wightman et al., 1993), the founding 
members  being  lin-4 and let-7.  MiRNAs  also  occur  in  flies,  mice  and  humans  and 
hundreds of these RNAs exist (He and Hannon, 2004) that act in combination with 
RNA-binding proteins to bind to the mRNA 3’untranslated region (UTR), through base 
pairing, and consequently gene expression is silenced by inhibiting translation. With the 	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exception  of  miRNAs  located  on  Alu-repetitive  regions,  which  are  transcribed  by 
RNAPIII, primary miRNAs are transcribed by RNAPII to form a primary (pri)-miRNA 
molecule of hundreds to thousands of nucleotides long that is cleaved by the RNase III 
enzyme Drosha to form a double-stranded (ds) hairpin-shaped precursor miRNA (pre-
miRNA; ~70-nt). pre-miRNA is transported to the cytoplasm of the cell and is cleaved 
again by another RNase III enzyme, Dicer (Bernstein et al., 2001; Bushati and Cohen, 
2007; Ketting et al., 2001; Tijsterman and Plasterk, 2004). Subsequently, Argonaute2 
(Ago2) is recruited and forms a trimeric ribonucleoprotein complex designated RNA-
induced silencing complex (RISC) (Gregory et al., 2005; Liu et al., 2004; Maniataki and 
Mourelatos, 2005). RISC and its target mRNA accumulate in processing-bodies (P-
bodies) where mRNA degradation happens (Liu et al., 2005; Pillai et al., 2005; Sen and 
Blau,  2005).  There  are  suggested  biological  function  of  miRNA  targeting  in 
embryogenesis  including  germ  layer  formation,  morphogenesis  and  organogenesis, 
control  of  developmental  timing,  neuronal  patterning,  haematopoietic  cell 
differentiation, and cell proliferation and death (Brennecke et al., 2003; Chang et al., 
2004; Chen et al., 2004; Johnston and Hobert, 2003; Lee et al., 1993; Pauli et al., 2011; 
Reinhart  et  al.,  2000;  Wightman  et  al.,  1993;  Yekta  et  al.,  2004).  Changes  in  the 
expression profile of miRNAs have been detected in tumors; indeed miRNAs can act as 
tumor suppressors such as miR-15a and miR-16-1or act as oncogenes such as miR-155 
miR-17-92 (Calin and Croce, 2006). Another type of small RNA, siRNA, differs from 
miRNA in that it can have several different sources and it cleaves target mRNAs that 
are either endogenous or viral RNA (Forstemann et al., 2007; Tomari et al., 2007). 	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1.10.3 New classes of ncRNAs 
1.10.3.1 Promoter-proximal short RNAs 
Short  RNAs  around  TSS  of  active  protein-coding  promoters,  termed  TSS-
associated  RNAs  (TSSa-RNAs)  or  promoter-associated  short  RNAs  have  been 
identified, which are transcribed within 1.0-1.5 kb from the TSS and are smaller than 
200 nt, some of them <22nt (Core et al., 2008; Kapranov et al., 2007; Seila et al., 2008; 
Taft et al., 2009). Such RNAs are predominantly associated with active and CpG islands 
promoters. Core et al study used a global run-on-sequencing (GRO-seq) assay, where a 
ribonucleotide analog is added to BrU-tag, to confirm that RNAPII is actively engaged 
in transcription (Core et al., 2008). Both studies found that short promoter-associated 
RNAs are transcribed in the sense and unexpectedly in antisense direction too (Core et 
al., 2008; He et al., 2008; Seila et al., 2008). TSSa-RNAs sense locate downstream of 
the TSS and peak at around +0 and +50 nt whereas antisense ones are detected upstream 
of TSS around -100 and -300 (Core et al., 2008; Seila et al., 2008). A relevant feature of 
these short RNAs is their highly significant association with CpG islands (Flynn et al., 
2011; Seila et al., 2008). Another type of small RNA, identified up to 5 kb upstream of 
promoter and designated “PROMPTs” have been found to be very unstable (Preker et 
al., 2008). These transcripts are actively transcribed by RNAPII (Core et al., 2008) and 
are not produced by Dicer, as they remain present in dicer-/- ESCs (Seila et al., 2008).  
Given  that  short  RNAs  have  been  discovered  around  transcription  start  sites 
(Core et al., 2008; Kapranov et al., 2007; Seila et al., 2008; Taft et al., 2009) and that 
polycomb target genes are often associated with H3K4me3 (Bernstein et al., 2006a) and 
RNA Pol II (Brookes et al., 2012; Stock et al., 2007), our laboratory hypothesized that 
short  RNAs  are  also  produced  from  repressed  polycomb  target  genes.    Using 	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microarrays, our laboratory identified short RNAs transcribed from the 5’ region of 
protein-coding genes in human CD4+ T-cells. The previous studies (Core et al., 2008; 
Kapranov et al., 2007; Seila et al., 2008; Taft et al., 2009) showed that short RNAs are 
transcribed mainly from active genes, but the short RNAs identified in our laboratory 
are  transcribed  from  both  mRNA-producing  and  non-mRNA-producing  genes, 
indicating that they are also transcribed from silent and polycomb-associated genes. 
This set of silent genes contained RNAPII that was positionally associated with the 
short RNAs. 
 
1.9.3.2 Long non-coding RNAs (lncRNA) 
The  advent  of  microarray  and  next-generation  sequencing  technologies  have 
allowed genome-wide identification of thousands of new transcripts (Carninci, 2009; 
Jacquier, 2009; Mattick et al., 2010). LncRNAs can be sense or antisense, and they can 
also act in cis or in trans, as already exemplified above. As far as known, most of 
lncRNAs are capped and polyadenylated and even though are not exported from the 
nucleus to the cytoplasm like mRNA but have no or little open reading frame (ORF) 
(Carninci et al., 2005). LncRNA show low sequence conservation except for a subset of 
these  RNAs  at  exons  (Brockdorff,  2013;  Brosius,  2005;  Struhl,  2007).  This  fact 
indicates that structure might be mainly responsible for ncRNAs activity rather than 
sequence. LncRNA control processes like imprinting, such as Airn (antisense to Igf2r 
RNA  non-coding)  and  Kcnq1ot1  (Kcnq1-overlapping  transcript  1);  dosage 
compensation as for Xist (X chromosome inhibition) (Nagano and Fraser, 2011; Wilusz 
et al., 2009); gene regulation, which can be in cis as it is the case of the lncRNA at the 
dihydrofolate reductase (DHFR) locus that binds to the DHFR promoter to inhibit its 
expression, or in trans it is the case of HOTAIR (HOX antisense intergenic RNA) (Pauli 
et  al.,  2011).  They  have  also  been  linked  to  cell  cycle  regulation  and  pluripotency 	 ﾠ 58	 ﾠ
(Nagano and Fraser, 2011; Wilusz et al., 2009) and can be developmentally regulated 
(Mercer et al., 2009). lncRNAs have also been found important in other cell types that 
not ESCs, for example the long non-coding RNA named Braveheart that is required for 
the cardiovascular lineage commintment (Klattenhoff et al., 2013). 
A  class  of  lncRNA  is  contained  within  intergenic  regions  and  therefore 
designated large intergenic RNA (lincRNA). LincRNAs can have a myriad of functions 
(Geisler and Coller, 2013; Guttman et al., 2009; Guttman et al., 2011; Huarte et al., 
2010; Hung et al., 2011; Orom et al., 2010; Wang et al., 2011; Wilusz et al., 2008). 
They exhibit a chromatin profile identical to active genes, thus being transcribed from 
H3K4 and H3K36 methylated regions (Guttman and Rinn, 2012). Some of them have 
enhancer-like function (Orom et al., 2010; Wang et al., 2011), and at least 30% of 
lincRNAs interact with one of multiple chromatin-regulatory complexes (Guttman et al., 
2011). These RNAs have suggested functions in ESC pluripotency and differentiation 
(Guttman et al., 2011; Pauli et al., 2011), for instance the lincRNA-RoR is a regulator of 
reprograming  of  cells  into  induced  pluripotent  cells  (iPSCs)  (Loewer  et  al.,  2010). 
lncRNAs have also been found important in other cell types than ESCs, for example the 
long non-coding RNA named Braveheart that is required for the cardiovascular lineage 
commitment (Klattenhoff et al., 2013). 
 
 
1.10.4 Polycomb-RNA interactions 
An important characteristic of RNA is that not only can it interact with protein 
complexes  but  it  can  also  bind  to  chromatin  bringing  the  possibility  of  ncRNA 
functioning to target protein complexes to specific genomic sites (Guttman and Rinn, 
2012). Although there is no evidence that ncRNAs are involved in the targeting of PcG 	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proteins  in Drosophila,  RNA  may  form  a  linkage  between  PcG  and  chromatin  in 
mammals (Beisel and Paro, 2011). Recruitment of polycomb complexes to mammalian 
target genes is still not well understood. However, mammalian PRC2 has been reported 
to interact with a wide range of lncRNAs (Rinn and Chang, 2012; Wang and Chang, 
2011) derived from intergenic and intragenic regions, and which have been suggested to 
be PcG recruiters (Pandey et al., 2008; Rinn et al., 2007; Zhao et al., 2008). 
Central  to  X-inactivation  in  female  mammals  (a  process  indispensable  for 
chromosome  dosage  compensation)  is  the  cis  acting  ~17  kb  X-inactive-specific 
transcript (XIST) that accumulates on the inactive X-chromosome (Xi) (Brockdorff et 
al., 1992; Brown et al., 1992; Plath et al., 2003). The first indication of a correlation 
between PRC2 and the Xi was the observation of an enrichment of EED/EZH2 and 
H3K27me2/3 on the Xi territory (Duthie et al., 1999; Mak et al., 2002; Plath et al., 
2003; Silva et al., 2003). Further experiments confirmed a correlation between XIST 
expression and PRC2 recruitment (Kohlmaier et al., 2004; Mak et al., 2004; Plath et al., 
2003). XIST contains a structure called RepA (A-repeat region) embedded within XIST 
intron 1. Rep A consists of A-rich spacer sequence followed by a 26-nt GC-rich core 
sequence forming a double stem-loop that repeats itself 7.5x to form a structure of 1.6 
kb (Brockdorff et al., 1992; Brown et al., 1992; Zhao et al., 2008). PRC2, particularly 
EZH2,  as  shown  by  EMSA,  binds  to  RepA  through  a  conserved  double  stem-loop 
(Zhao et al., 2008). However, the interaction is not very specific given that Ezh2 can 
also interact with antisense RNA. Furthermore, RepA alone is not the key recruiter of 
PRC2  as  RepA-lacking  XIST  can  also  recruit  PRC2  (Kohlmaier  et  al.,  2004).  The 
localization domain of XIST, RepC, binds to YY1. YY1 also tethers to this non-coding 
RNA, bringing it to X nucleation centre (Jeon and Lee, 2011). Inactive X chromosome 
(Xi) is largely occupied by H3K27me3, and monoubiquitylation of H2A has also been 
linked  to  Xi  (Bernstein  et  al.,  2006b;  de  Napoles  et  al.,  2004;  Smith  et  al.,  2004). 
Members of PRC1 have been shown to associate with Xi including most of the CBX 	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members (not CBX4) (Bernstein et al., 2006b; de Napoles et al., 2004; Hernandez-
Munoz et al., 2005; Plath et al., 2004). CBX7, is particularly enriched in the inactive X 
chromosome (Bernstein et al., 2006b). Recently, the chromatin remodeller ATRX has 
been  demonstrated  to  directly  interact  with  RepA/Xist,  which  is  required  for  PRC2 
loading on XIST (Sarma et al., 2014).  
Another  PRC2-interacting  ncRNA  is  the  2.2-kb  HOTAIR  (Hox  antisense 
intergenic RNA) located on human chromosome 12, which acts in trans (Gupta et al., 
2010;  Rinn  et  al.,  2007).  HOTAIR originates  from  the  HOXC locus  but  appears  to 
function  to  repress  the  HOXD cluster  region  on  chromosome  2  by  interacting  with 
PRC2, through its 5’-end, and adding H3K27me3 marks across a 40kb region (Rinn et 
al., 2007). How HOTAIR is directed to its targeting sites is unknown. HOTAIR is over 
expressed  in  some  primary  tumors;  this  overexpression  induces  genome-wide 
retargeting of PRC2 and can be indicative of metastasis and poor prognosis (Gupta et al., 
2010; Kogo et al., 2011). This ability of HOTAIR to confer cellular invasiveness is 
specifically dependent on PRC2 (Gupta et al., 2010). The HOTAIR 3’-end has been 
found  to  interact  with  LSD1,  a  component  of  CoREST/REST  that  has  demethylase 
activity against H3K4 (Tsai et al., 2010). It seems that lncRNAs may contain multiple 
binding  sites  for  different  proteins,  thus  directing  and  combining  different  histone 
modifications. Similar to HOTAIR, thousands of other lncRNAs have been identified in 
different  organisms  that  associate  with  chromatin  remodeling  complexes,  including 
PRC2, and this interaction is required for their function (Khalil et al., 2009).  
Another PRC2-interacting lncRNAs is the 91kb transcript from the imprinted 
potassium voltagegated channel, subfamily Q, member 1 (Kcnq1) cluster, termed Kcnq1 
overlapping transcript 1 (Kcnq1ot1), located on mouse chromosome 7. In this case, the 
cluster of paternal alleles is repressed by the expression of Kcnq1ot1, and deletion of 
the  Kcnq1ot1  promoter  results  in  loss  of  imprinting  of  most  genes  of  that  cluster 
(Fitzpatrick et al., 2002). Kcnq1ot1 requires direct interaction of PRC2 with Kcnq1ot1 	 ﾠ 61	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ncRNA for spreading of H3K27me3 throughout the locus (Pandey et al., 2008). 
BMI1 and CBX7 have been reported to repress the INK4b/ARF/INK4a locus, a 
master regulator of cellular senescence in case of stress (Bernard et al., 2005; Gil et al., 
2004). This repression is mediated by ncRNA ANRIL (antisense non-coding RNA in 
the INK4 locus), which binds to the CBX7 subunit of PRC1 through its chromo domain, 
and causes repression in cis (Yap et al., 2010). ANRIL is an antisense noncoding RNA 
that  spans  along  30–40  kb  of  the  INK4b/ARF/INK4a locus  (Pasmant  et  al.,  2007). 
Human MOV10, a putative RNA helicase previously implicated in post-transcriptional 
gene silencing, associates with CBX7 and is required for repression of Ink4a/Arf and the 
presence of H3K27me3 (El Messaoudi-Aubert et al., 2010). 
In this introduction I have reviewed the involvement of the polycomb group of 
proteins  in  animal  development,  their  function  and  what  is  known  about  their 
mechanism  of  action.  It  is  still  poorly  understood  how  these  proteins  interact  with 
chromatin  despite  the  advances  in  recognizing  ncRNA  as  an  intermediate.  It  is  not 
known  how  these  RNAs  are  regulated,  and  how  specifically  they  interact  with 
polycomb proteins. Although the functions of a subset of lncRNAs have been identified 
and  correlated  with  changes  in  gene  expression,  the  majority  of  ncRNAs  have  no 
assigned  function,  opening  the  possibility  of  new  functions  potentially  linked  with 
protein binding. It is also being considered how environmental factors affect such RNA 
functionality and regulation.  
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Aims of this project 
PREs  are  well  defined  in  Drosophila  allowing  for  their  prediction  in  this 
organism but not so well characterized in mammals due to lack of consistency found in 
this sequence. However, it has been observed that they contain PRC2-interacting CpG 
island and that PRC2 also interacts with RNA, leading to the hypothesis that these 
might constitute features of mammalian PREs. 
Some genes are regulated at the level of elongation and poised for activation.  As 
RNAPII and transcription positive marks are associated with polycomb-targeted genes, 
I hypothesised that short RNAs are transcribed from DNA regions around the TSS of 
many genes regulated by polycomb, and that these same regions might behave a PREs 
like in Drosophila. 
This project has two principal aims. Firstly, to investigate whether short RNAs 
are transcribed from repressed polycomb target genes and whether this is a result of 
polycomb activity. Secondly, to investigate whether the DNA regions that produce short 
RNAs behave as PREs. 
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Chapter 2 – Methods 
 
2.1 RNA purification and fractionation 
Total RNA was purified using TRizol was as follows: 1x10
7 pelleted cells per 
millilitre  of  TRizol  were  dissolved  by  pipetting  and  vortexing,  while  lysate  was 
incubated for 5 min at room temperature (RT). 0.2 ml of chloroform was added, the 
lysate shaken by hand for 15 seconds and incubated for 5min at RT. The organic and 
aqueous layers were then separated by centrifugation at 12,000g for 15 min at 4ºC. 
0.5  ml  of  the  top  aqueous  layer  was  pipetted  into  a  fresh  tube  and  0.5  ml  of 
isopropanol  was  added.  This  was  vortexed  and  RNA  allowed  to  precipitate  by 
incubating at RT for 10 min, then pelleted by centrifugation at 12,000g for 15 min at 
4ºC. The supernatant was discarded and the pellet washed by adding 1ml of 75% 
Ethanol,  followed  by  vortexing  and  centrifuging  at  7500g  for  10min  at  4ºC. 
Finally,  pellet  was  dried  for  5  min  at  RT  and  dissolved  in  RNase-free  water 
(Ambion). When required, total RNA was fractionated into long and short (≤200 nt) 
using a mirVana miRNA kit (Ambion) by following the manufacturer’s instructions. 
Purified RNA was quantified using a nanodrop. 
For short RNA purification using RNAzol, 1x10
7 cells were dissolved in 1ml 
of RNAzol, vortexed and 0.4 ml of double distilled water added into the lysate. The 
solution was mixed by manual stirring for 15 seconds and incubated for 10 min at 
RT. Cell debris was pelleted by centrifuging at 12,000g  for 15min at 4ºC, and 1 ml 
of the aqueous phase, containing total RNA, was transferred  to a new  tube.  0.4  ml 
of  75%  ethanol  was  added,  solution  was  vortexed,  incubated  for  10  min,  and 
centrifuged at 12,000 g for 8 min at 4ºC to precipitate long RNA. 1ml of supernatant 
containing short RNA was pipette into a new tube and stored at -20ºC. The long 
RNA  fraction  was  washed  by  adding  0.4  ml  of  75%  ethanol,  vortexed  and 	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centrifuged 8,000 g for 3 min. Supernatant was discarded and the pellet washed a 
second  time.  Residual  supernatant  was  removed  with  a  micropipette  and  RNA 
resuspended in RNase-free water without drying. For shrt RNA purification, 0.8 ml 
of  isopropanol  added  to  the  samples,  vortexed  and  precipitated  at  -20ºC  for  30 
min,  then  centrifuged  at 12,000 g for 20 min. The short RNA pellet was washed 
twice  in  0.4  ml  of  70%  isopropanol,  centrifuged  at  8,000  g  for  3  min,  and  re-
suspended in water the same way as long RNA. 
RNA was treated  with DNase-turbo (Ambion) at 37ºC for 30 minutes. For 
total purified RNA, DNase was stopped by addition of 1/10
th volume of terminator 
mix (0.1M EDTA pH 8.0, 1 mg/ml glycogen). Total and short DNased RNAs were 
purified by ethanol precipitation at -20ºC for 30 min, then centrifuged and washed 
as described above. Total, long,  and  short  RNAs  were  examined  with  an  Agilent 
Bioanalyzer  to  confirm  RNA  quality  and  fractionation  size.  Short  RNA  was 
purified from PBMCs, neurons and ES cells  with TRizol and from MSC and drug-
treated CEM cells with RNAzol.  
In a test experiment to analyse differences between the two methods, RNA 
was  purified  in  parallel  from  CEM  cells  with  TRizol  and  RNAzol.  Equivalent 
amounts  of  each  fraction purified with RNAzol were also pulled together and re-
fractionated using the mirVana miRNA kit. 
 
2.2 Northern blotting 
5 µg of DNase-treated short RNA was mixed with loading buffer (Ambion) 
and heated to 95ºC for 5min, and then loaded into 15% acrylamide-7M Urea TBE 
Novex gels (Invitrogen). Denatured RNA was resolved in 1X TBE in parallel with 
radio-labelled Century and Decade markers  (Ambion)  for  1hr  at  200V.  The  RNA 	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was electroblotted to a Nytran Supercharge membrane (Whatman) for 1.5hr with a 
starting current of 200mA. 0.5X TBE was used as the  running  buffer.  Fixation  to 
the  membrane  was  performed  by  UV-crosslinking  using  1200mJ,  followed  by 
baking it for 1hr at 80ºC. The 49-nt northern probes used to detect the short RNAs in 
human cells (PBMCs, SH-SY5Y) were  designed based on the 60-nt microarray 
probes (Table 3).  The mouse probes were chosen based on homology to the 
human microarray probes. Probes to detect novel short RNA in the HOXD11.12 
PRE were designed across the entire element (Table 4) based on the DNA sequence 
extracted  by  Woo  et al.  (2010).  The  probes  were  produced  by  Integrated  DNA 
Technologies,  are  49  nucleotides  long,  and  contain  a  3’  StarFire  extension 
system  for  labelling.  Radioactive  labelling  was  carried  out  according  to 
manufacturer’s  instructions,  and  MicroSpin  G-25  (GE  HealthCare)  columns  were 
used to purify labelled probes. Before probing, membranes were pre-hybridised in 
UltraHyb buffer (Ambion) at 35ºC for 30 min. Labelled and purified probes were 
added  into  the  buffer,  and  left  to  hybridize  at  35ºC  for  16hr.  The  washes  were 
performed with a solution composed of 2X SSC and 0.5% SDS, and consisted of 
three washes at 35ºC for 5min each with a fourth wash at 42ºC for 5-10min. The 
membranes  were  then  exposed  to  a  phosphor  screen  for  at  least  48hr.  The 
phosphor  screen  was  scanned  using  a  STORM  phosphoimager 
(Molecular Dynamics). Blotting for the murine knockout cell lines was performed 
with the help of lab colleague Aditi Kanhere. 
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2.3 Cell culture 
	 ﾠ
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Mesenchymal stem cells 
Immortalised  Mesenchymal  Stem  Cells  (MSC)  (Funes  et  al.,  2007)  were 
cultured  at 37ºC and 5% CO2 in  MesenCult®  MSC Basal Medium (Human) 
with 10% MesenCult® Mesenchymal Stem Cell Stimulatory Supplement (Human) 
until ~60% confluency. Human primary MSC have limited proliferative potential in 
vitro.  
 
Neuronal cells 
SH-SY5Y  cells  were  cultured  in  DMEM  with  10%  FCS  until  40-50% 
confluent  and  then  terminally  differentiated  in  DMEM  with  5%  FCS  and  10µM 
retinoic acid (Sigma) for 7 days. 
 
PBMC purification 
Peripheral blood mononuclear cells were isolated from standard buffy coat by 
gradient centrifugation using lymphoprep. Blood was diluted 1 in 4 HBSS. Lymphoprep 
and HBSS were warmed to 37ºC. 15 ml of Lymphoprep were added to six 50 ml Falcon 
tubes and 35 ml of diluted buffy coat was carefully layered on top and centrifugated at 
1600 rpm, brake zero, for 30 minutes. Interphase layer was removed into a new tube. 
Then spun at 1600rpm for 10 minutes, brake nine; supernatant discarded and pellet 
gently resuspended in 50 ml HBSS. 
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CEM cells 
CEM were grown in RPMI-1640 medium supplemented with 10% Fetal calf 
serum (FCS) and 1% streptomycin/ Penicillin. 
 
Murine ES cells 
The growth of Ezh2 knockout cell lines (Ezh2-1) (Landeira et al., 2010; Su et 
al., 2003) was performed by Filipe Pereira and Cynthia Fisher, while the growth of 
Ring1B knockout cell lines (ES-ERT2) (Endoh et al., 2008; Stock et al., 2007) was 
carried out by Emily Brooks. Murine  ES differentiation into motor neurons (Wichterle 
et al., 2002; Wichterle and Peljto, 2008) was accomplished by Warren Whyte. 
 
2.4 Quantitative reverse-transcription PCR 
Total  RNA  was  purified  from  the  mouse  ES  cell  differentiation  stages, 
Ring1B  and  Ezh2  knockout  cell  lines,  and  drug  treated  CEM  cells,  and  treated 
with  DNase  turbo.  Samples  were  then  reverse  transcribed  with  SuperScriptII 
(Invitrogen) primed with oligo-dT or random primers for RNA extracted from CEM 
cells  for  the  RNAPII  inhibition  study  described  below.  Controls  with  no  reverse 
transcriptase  were  performed  to  ensure  that  qPCR  products  are  cDNA  derivates. 
Samples were subjected to SYBR green quantitative PCR (Qiagen) containing 5-15 
ng  cDNA  and  a  primer  concentration  of  300nM.  Change  in  the expression  of 
Ybx2,  Msx1,  Hes5 and  Pcdh8,  in  the murine cell lines, was calculated relative to 
day 0 and normalized to Actin using the formula ‘gene of interest’/Actin. The amount 
of  nascent  Actin  RNA  in  the  RNAPII  inhibition  experiment  was  measured  by 
comparing the Ct to that of 5S rRNA using the formula 2
(Ct(5S rRNA) – Ct(β-Actin)). 	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2.5 Chromatin immunoprecipitation 
The Chromatin immunoprecipitation (ChIP) protocol followed that of Lee and 
colleges (Lee et al., 2006). MSC were grown as described above and crosslinked by 
addition  of  1%  formaldehyde  to  the  culture  medium  for  10  minutes  at  room 
temperature. Formaldehyde was quenched with 0.125M of glycine, the cells washed 
twice with cold PBS, scraped from the plate surface, washed twice with cold PBS and 
then flash frozen and stored at -80ºC.  Cells  were lysed by re-suspension  in  lysis 
buffer  1  (50mM  Hepes  KOH  pH7.5,  40mM  NaCl,  1mM  EDTA,  10%  glycerol, 
0.5% IGEPAL CA-630, 0.25% Triton X-100) rocked for 10 min at 4ºC, centrifuged 
and  the  entire  process  repeated  with  lysis  buffer  2  (10mM  Tris  pH  8,  200mM 
NaCl,  1mM EDTA, 0.5mM EGTA). Extracted nuclei were re-suspended in buffer 
3  (10mM  Tris  pH  8,  100mM  NaCl,  1mM  EDTA,  0.5mM  EGTA,  0.1%  sodium 
deoxycholate, 0.5% N-lauryl sarcosine) and sonicated on ice at 24W for 5 minutes 
total (pulses of 30s separated for gaps of 1 minute) with a Misonix Sonicator 3000. 
Complete  protease  inhibitor  (Roche)  was  added  to  each  buffer.  100  µl  Dynal 
Protein G magnetic beads were coated with 10 µg of respective antibody by 8 hr 
incubation at 4ºC, and washed. Antibodies used were: H3K27me3 (Abcam ab6002), 
H3K4me3 (Abcam ab8580), and H3 (Abcam ab1791). Sonicated cell lysate (whole 
cell  extract)  from  5x10^7  MSCs  was  immunoprecipitated  overnight  with  the 
antibody-coated  beads  at  4ºC.  100  µl  of  whole  cell  extract  was  preserved  to  be 
used as a control. Beads were washed 5 times with RIPA buffer (25mM Tris-HCL, 
150mM NaCl, 1%NP-40, 1% sodium deoxycholate, 0.1% SDS) and once with TE 
containing 50 mM NaCl. To elute the immunocomplex from the beads these were 
incubated at 65ºC for 1hr with vortexing every 10 minutes, and then pelleted. The 
supernatant was then left incubating for an additional 6 hr in order to reverse the 	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protein-DNA  crosslinks.  Control  whole  cell  extract  was  also  reverse  crosslinked. 
Samples were  then  treated  with  8  µl  RNAseA (10 µg/µl),  and  4  µl  proteinase  K 
(20 µg/µl).  Immunoprecipitated  and whole cell extract  DNA  were  purified  by 
phenol:chloroform:isoamyl  alcohol  phase  separation  and  ethanol  precipitation  and 
then quantified using a nanodrop. Quantitative PCR (qPCR) was performed using the 
SYBR green PCR (Qiagen) system. Samples contained 5-15 ng cDNA and a primer 
concentration  of  900 nM for HOXD11.12, 600 nM for HOXC8, and 300 nM for 
Actin primers. To quantify ChIP vs input DNA, serial 1/10 dilutions of whole cell 
extract (WCE) were prepared to construct a standard curve.  
 
2.6 RNA secondary structure 
The stem-loop-stem  structure  motif  in  RepA  interacts  with  PRC2 (Zhao et 
al.,  2008).  Using  the  RepA  RNA  structure  as  a  model,  prediction  of  RNA 
structures was performed with the help of Aditi Kanhere. Structures were identified 
within  200nt  of  sequence  surrounding  probes  that  detected  short  RNAs  using 
RNAmotif  (Macke  et  al.,  2001).  Free-energy  structures  were  predicted  using 
RNAfold (Hofacker and Stadler, 2006). 
 
2.7 RNA polymerase II inhibition 
CEM cells were grown to confluency (1x106 cells/ml), and 1x108 cells were re-
suspended  in  100  ml  of  medium  per  treatment.  Cells  were  treated  with  10  µM 
Flavopiridol  (4.56mM  stock  concentration;  Invitrogen),  or  5µg/ml  ActinomycinD 
(10mg/ml  stock  concentration;  Sigma)  for  10 hours.  A  control  sample  received  no 
drug treatment. One hour after adding the drugs, 2ml of cell suspension were aliquoted 
to  use  as  a  control  for  drug  inhibition  of  RNAPII  by  stimulating  the  cells  to 	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differentiate,  which  was  accomplished  with  50  ng/µL  of  PMA  and  500  ng/  µL  of 
Ionomycin added into one ml of each sample, the other one ml was used as a control. 
Therefore,  after  the  10  hours  treatment,  control  samples  for  drug  inhibition  were 
stained  with  anti-CD69-PE  antibody  (Miltenyi).  First  cells  were  washed  in  PBS 
containing 4% FCS, 5 µL antibody were added and incubated for 15 min at 4ºC in the 
dark. Cells were crosslinked with 2% formaldehyde and washed in PBS before being 
analysed by flow cytometry.This will allow the drug to inhibit for the transcription of 
mRNA  including  CD69.  After  drug  treatment,  test  cells  were  centrifuged  at 
12,000rpm  for  5  min  and  resuspended  in  RNAzol  for  a  final  concentration  2x107 
cells/ml.  
 
2.8 Cloning 
The HOXD11.12 PRE was identified from Woo et al (2010), and potentially 
new  PRE  sequences  were  identified  from  regions  with  short  RNAs  flanked  by 
H3K27me3  peaks.  Primers  underlying  the  H3K27me3  peaks  were  designed  to 
amplify these regions by PCR (Table 2). The sequences between each of the two 
peaks  were  amplified  from  genomic  DNA  from  human  PBMCs.  Pfx50  or  Pfu 
DNA  polymerases  (Invitrogen)  were  used  because  they  produce  fragments  with 
blunt  ends.  The  fragment  sizes  were  confirmed  by  gel  electrophoresis,  then 
purified  and  ligated  with  T4  ligase  (Promega)  into  the  pCR-Blunt  Vector 
(Invitrogen).  A  ligation  control  was  performed with  water.  The  ligation  products 
where transformed into TOP10 E. coli competent cells (Invitrogen) by heat shock. 
Cells were grown in Luria-Bertani broth (LB) at 37ºC overnight, and the plasmids 
were extracted with Miniprep Kit (QIAgen). The presence of insert and orientation 
was checked by sequencing. The subcloned inserts were separated from the  pCR-
Blunt vector by digestion with XbaI for MSX1, SpeI and XbaI for YBX2, and SpeI 	 ﾠ 71	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and  NheI  for  RASL12,  all  have  compatible  overhang  ends.  To  linearise  the 
luciferase  vector,  YY1pLuc  was  digested  with  NheI  (Promega).  Following  2hr 
digestion,  the  vector  was  treated  with  CIAP  (Promega)  to  avoid  self- ligation. 
Presence  and  orientation  of  insert  were  checked  by  sequencing.  Ligation, 
transformation  and  plasmid purification  were performed as above. 
 
2.9 Deletions in D11.12 PRE 
The  northern  blot  probes  that  detected  short  RNAs  corresponded  to  a  DNA 
sequence  of  150  base  pairs.  To  delete  this  short  RNA  sequence,  the  region  of 
HOXD11.12  upstream  of  the  short  RNA  area  (5’D11.12)  from  HOXD11.12 
YY1pLuc was amplified to produce a fragment with recognition sites for SacI at one 
end of PCR product and NheI at the other end. The 5’HOXD11.12 fragment and empty 
YY1pLuc  vector  were  digested  with  these  enzymes,  ligated  together,  and  the 
resultant clone linearized with AgeI and NheI. The HOXD11.12 region downstream 
of short RNA (3’HOXD11.12) was amplified with primers enclosing recognition sites 
for  AgeI  and  NheI,  and  ligated  into  the  vector  containing  the  5’HOXD11.12. 
HOXD11.12  with  deleted  short  RNA  sequence  (∆shortRNAD11.12)  was 
confirmed  by  sequencing.  HOXD11.12  PRE  with  deleted  conserved  region  was 
obtained from Woo et al (2010). Disruption of short RNA secondary structure was 
performed  using  site  directed  mutagenesis,  following  the  QuikChange  protocol 
(Stratagene) (Liu and Naismith, 2008). According to this method, forward and reverse 
primers align only for 17 nt (primer-primer complementary sequence; pp) and the  non-
overlapping  (no)  comprises  a  longer  sequence  that  requires  a  higher  melting 
temperature.  A  mutation  was  created  for  each  first  and  second  short  RNAs  of 
HOXD11.12 consisting of a 10nt long change in DNA sequence located on the pp 
region of each primer, designed using RNAFold to search for a mutation that would 
disrupt the secondary structure. 30 ng of template DNA (D11.12pYY1Luc) were used 	 ﾠ 72	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in a 50 µL reaction with Pfx Accuprime polymerase. PCR cycles used for the first and 
second mutation were as follows: 15 times (95ºC, 1min; Tm no -5ºC, 1min; 68ºC, 8min) 
plus Tm pp -5ºC, 1min and 68ºC, 30 min. 10 µL of PCR reaction plus loading buffer 
were ran by gel electrophoresis (0.8% agarose) using template plasmid as a control to 
confirm amplification. After the first cycle and before the second one the plasmid was 
cloned  into  TOP10  E. coli  and  isolated.  Samples  were  sequenced  to  check  for  any 
unwanted mutation, and subsequently miniprepped.  
 
2.10 Luciferase assay 
The following procedure is adapted from the work of Woo et al. (2010). The 
parental pTranslucent (pLuc) (Panomics) expresses a firefly luciferase reporter gene 
from  a  Herpes  simplex  virus  thymidine  kinase promoter,  but  has  low  expression 
levels (Woo et al., 2010). In order to promote luciferase expression, another vector 
was  used  with  an  YY1 enhancer  sequence  introduced  upstream  of  the promoter 
(YY1pLuc).  New  PREs  and  D11.12  PRE  were  inserted  immediately  upstream  of 
the YY1 enhancer. Transfected constructs were as follows: pLuc, YY1pLuc, D11.12 
YY1pLuc,  ∆shortD11.12  YY1pLuc,  and  control, pIRESneo3  LTR  C20orf112mut 
Luc,  a control previously used in our lab 3x10
3 cells were seeded into each well of a 
96-well  plate.  Cells  were  transfected  with  Fugene  HD  (Roche)  12  hrs  later 
using  a  6:2  Fugene:DNA  ratio  and  adding  to  each  well  75%  of  standard 
volume.  The  Renilla  luciferase  plasmid  (pRL-TK)  (Promega)  was  used  as  the 
assay  control.  Both  luciferases were  measured  with  the Dual-Luciferase  Reporter 
Assay  System  (Promega)  48  hr  post-transfection. Results were first normalized to 
pRL-TK and then further normalized so  that pLuc RLU represented 0% activity and 
YY1pLuc 100%.   	 ﾠ 73	 ﾠ
Chapter 3 – Regulation of short RNA transcription at 
polycomb target genes 
 
3.1 Introduction   
The small RNAs identified by Seila et al. (2008) and Core et al. (2008) were 
detected in ESCs and cell lines. Our laboratory also detected thousands of short RNAs 
from  promoter,  introns,  and  exons  of  protein-coding  genes  of  human  CD4+  T-cells 
indicating that production of small RNAs is a common feature of the transcriptome of 
somatic  cells  (Kanhere  et  al.,  2010).  Short  RNAs  detected  in  our  laboratory  are 
concentrated at 700 bp either side of the TSS, are 50-200 bp long, are from sense strand, 
and some of them were located on the same genes as TSSa-RNAs but on different 
positions. Furthermore, they could be detected from both active and silent genes equally, 
whereas only small RNAs have been previously detected only at active genes.  
Concordant with production of short RNA, RNAPII was located at the site of 
these short RNAs. H3K4me3 was also found present at the same location as RNAPII on 
these silent genes, with H3K27me3 peaks flanked by RNAPII and H3K4me3. These 
features  correlate  with  described  transcriptional  pausing,  a  common  mechanism  of 
regulating polycomb-target genes. These results show that these short RNA-producing 
silent genes are targets of polycomb. In Drosophila, Polycomb often targets TSSs with 
a stalled RNAPII and is linked to the production of short RNAs (Enderle et al., 2011; 
Kharchenko et al., 2011). 
Using  RepA  –  the  Xist  RNA  element  responsible  for  PRC2  binding  –  as  a 
positive control, our laboratory utilized electrophoretic mobility shift assay (EMSA) 
and RNA immunoprecipitation (RNA IP) to successfully demonstrate that short RNAs 
also  interact  with  PRC2.  Furthermore,  our  laboratory  has  identified  SUZ12  as  the 
binding subunit, and that binding is dependent on the secondary structure of the short 
RNAs. SUZ12 was not observed to bind to the RepA sequence encoded by ssDNA, 	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dsDNA or a RNA-DNA duplex. This interaction was also true in living cells and when 
incorporating the short RNA in the HIV LTR and submitting it to luciferase activity it 
lead to gene repression in cis.  
Given the production of short RNAs at paused polycomb targeted genes, and that 
PRC1 inhibits RNAPII elongation through H2A ubiquitination, we hypothesized that 
short  RNAs  are  a  by-product  of  polycomb  activity  and  therefore,  dependent  on 
H3K27me3  and  H2AK119ub.  Furthermore,  polycomb-tarfeted  neuronal  genes 
constitute  a  subset  of  polycomb  targets,  which  means  that  as  ESCs  differentiate  to 
primary motor neurons (PMN) and the genes becomes activated short RNAs should 
resolve. 
 
3.2 Results 
3.2.1 Purifying different lengths of short RNA  
The RNAs identified in our laboratory are short in length. RNA purification 
begins with total RNA extraction, followed by fractionation which can be accomplished 
by two methods: TRIzol or RNAzol. In order to assess whether TRIzol and RNAzol 
methods of RNA purification are equivalent, RNA was purified from a CEM cell line 
using  the  two  methods  in  parallel.  TRIzol  purifies  total  RNA,  which  then  requires 
fractionation using the mirVana system, while RNAzol purification separates short (≤ 
200  nt)  and  long  RNA  fractions  in  one  step.  To  better  address  any  possible 
difference between the two methods, RNA was purified with RNAzol alone, 
with TRIzol an mirVana and thirdly, by pooling equal proportions of the 
short and long RNA fractions purified by RNAzol back together and re-fractionated 
using  the  mirVana  system.  Northern  blotting  for  short RNA from HOXC6 has been 
shown to produce short RNA in T-cells and MSC. This blotting revealed that the short 
RNA  fraction  purified  directly  with  RNAzol  lacks  the  ~200nt  short RNA  that  are 
present in RNA purified with TRIzol and mirVana. This RNA can be observed when 	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long  and  short  RNAzol  fractions  are  pooled  together  with  long  RNA  and  re- 
fractionated  through  total  RNA  purification  with  the  mirVana  system  (Figure  6). 
Therefore, ~200 nt RNAs fractionate into the long RNA fraction upon purification via 
RNAzol. It was consequently determined that TRIzol and mirVana were most suitable 
for subsequent experiments as it was possible to maintain a greater ranger of short RNA 
species.  
	 ﾠ
Figure 6: Test for the fractionation of small RNA by different methods. Northern blotting in 
CEM cell line to compare two different methods of RNA purification and short RNA fractionation: 
A two step method involving first total RNA purification (with TRIzol) and then fractionation (with 
mirVana); and the other method that purifies and fractionates in a single step (with RNAzol). 
Lane 1 – short RNA purified with RNAzol, Lane 2 – short RNA purified with RNAzol, the two 
fractions were pooled together and re-purified with the mirVana system, Lane 3 – short RNA 
purification with TRIzol and the mirVana system. 
 
 
3.2.2  Short  RNAs  transcribed  from  silent  genes  are  conserved  between 
human and mouse 
Our laboratory has previously detected short RNAs in primary resting CD4+ 
T-cells. It was first verified whether short RNAs could indeed be produced from the 
promoter region of silent genes in mouse  ESCs. Moreover, conservation is a sign of 
functional significance. To analyze this,  H3K27me3  and PRC2  ChIP-Chip  data  from 
Boyer  et al. (2006) were used to identify genes targeted by Polycomb in murine ES 
cells. These set of genes was compared to the set of genes producing short RNAs 	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identified in T-cells, to select for common genes silenced in both cells types and to 
identify  short  RNA  sequences  conserved between human and mouse (performed by 
laboratory  colleague  Aditi  Kanhere).  Probes  for  northern  blotting  were  designed  to 
detect  murine  Pcdh8,  Ybx2,  Hes5  and  Msx1  short  RNAs.  The  blots  showed  short 
RNA bands  for  all these  genes,  therefore  I  have  demonstrated  that  they  are  also 
transcribed in murine ES cells (Figure 7A and B). This supports strong evidence that 
production of short RNAs at Polycomb targets is conserved between these mammalian 
species and between ES cells and T cells. 
 
  
Figure 7: Short RNA is conserved between human and mouse. (A) Northern blotting for 
detection of short RNAs extracted from human CD4+ T-cells. RASL12, YBX2, PAX3, HOXC6, 
HOXA7, C20orf112, BSN, HES5, NKX2-1, MARK1, and NKX2-2 are repressed in this cell type. 
The size of markers is shown on the left side in nucleotides. Short RNAs are sized around 200–
50 nt on the probed genes. (B) Northern blotting for detection of short RNAs extracted from wild-
type murine ES cells. Pcdh8, Ybx2, Hes5 and Msx1 genes are repressed in murine ES cells. 
The size of markers are shown on the left side in nucleotides. RNAs are sized around 100 nt on 
exons of Pcdh8 and Msx1; and around 200 nt for Ybx2 exon and Hes5 promoter. Short RNA 
production is therefore shown to be conserved from mouse to human.   
A 
	 ﾠ B 	 ﾠ 77	 ﾠ
3.2.3 Short RNA transcription is independent on polycomb activity  
Given that Polycomb-repressed genes contain stalled RNA polymerase, due to 
ubiquitination of H2AK119,  short  RNA  might be  a by-product of  PRC2  repressive 
activity.  To  evaluate  the validity of this assumption, further work was carried out in 
collaboration with Amanda Fisher’s group. They have generated a murine ES cell line, 
Ezh2-1.3, that uses a tamoxifen-inducible cre-lox system to create a null mutation to 
delete the  catalytic  SET  domain  of  Ezh2,  which  was  subsequently  cultured  in  the 
presence of tamoxifen for five days by Filipe Pereira. 
To confirm that the inducible knockout is effective, H3K27me3 and Ezh2 were 
analysed for five  days  after tamoxifen  treatment  by  western  blotting  (performed  by 
Keijo Viiri). As indicated in the western blot, the Ezh2 SET domain is abolished one 
day  after  addition  of  tamoxifen  and  a  truncated  form  of  Ezh2  appears,  which  is 
accompanied  by  loss  of  H3K27me3  (Figure  8A).  In  contrast,  blotting  for  short 
RNAs  showed  that  short  RNAs  do not  show  a  change  in  abundance  four  to  five 
days after adding tamoxifen (Figure  8B).  5S  rRNA  was  used  as loading control. In 
order  to  confirm  that  short  RNA  transcription  are  also  unaffected  by  loss  of  PRC2 
function,  JARID2
-/- murine knockout from Fisher’s laboratory was utilized (Figure 8C). 
Northern blotting revealed that short RNAs are also transcribed from Msx1 and Hes5 in 
these cell lines, consistent with the results from the Ezh2 deletion experiment. These 
results  demonstrate  that  production  of  short  RNA  is  indeed  independent  and 
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 H2A ubiquitination has been suggested to be involved in polymerase stalling 
(Stock et al., 2007), implying that this might be the polycomb component responsible 
for the short RNA production. H2A ubiquitination is catalysed by the PRC1 subunit 
Ring1B. A murine ES  cell line, Es-ERT2,  was used to test the dependency of short 
RNAs on  H2AK119ub. Es-ERT2 contains a tamoxifen-inducible conditional knockout 
of  the  Ring1B  and  is  also  homozygous  null  for  the functional homologue Ring1A. 
Following  addition  of  tamoxifen,  cells  are  progressively  depleted  of  H2Aub  but 
preserve the overall levels of PRC2 and H3K27me3 (Endoh et al., 2008; Stock et al., 
2007). These cells were grown by Emily Brooks (MRC CSC). Blotting for short RNAs 
at Hes5, Msx1, and Ybx2,  showed that  loss  of  Ring1b  had  no  effect  on  short  RNA 
transcription (Figure 8D). Es-ERT2 and Ezh2-1.3, cells could have been treated with 
tamoxifen for more than 3 or 5 days respectively; however, longer treatments induce 
cell differentiation because of the activation of differentiation-associated genes. This 
indicates  that  short  RNAs  are  transcribed  independently  of  Ring1B  activity  and 
independently of the H2Aub-mediated block to elongation and are not degraded within 
the time-frame of tamoxifin induction.  
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Figure 8: Transcription of short RNAs from cells lacking Polycomb subunits. (A) Western 
blotting  for  H3K27me3,  and  Ezh2,  in  Ezh2-1.3  cell  line  (Ezh2  knockout)  (by  Keijo  Viiri)  to 
measure the efficacy of deletion of the SET domain, which contains histone methyltransferase 
activity. Measurements were made before the addition of tamoxifen (day zero) and over a time 
course of five days after addition of tamoxifen. Two days after the addition of tamoxifen, Ezh2 is 
mutated and H3K27me3 disappears. Antibody against H3 was used as a loading control. (B) 
Northern blotting of short RNA in murine Ezh2-1.3 cell line at the genes Ybx2, Msx1, and Hes5. 
Short RNAs were measured in a 5-day treatment course after addition of tamoxifen. Day zero 
was used as a control before  addition of  tamoxifen.  Production of  short RNA  is  maintained 
constant along the time course treatment. Short RNAs have a size of around 200 nt in Hes5 and 
Ybx2, and around 90 nt for Msx1. 
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Figure 8: Transcription of short RNAs from cells lacking Polycomb subunits. (C) Northern 
blotting for short RNA transcribed from Msx1 and Hes5 in Jarid2 knockout cells, wild type (+/+),  
JARID2 heterozygous (+/-), and JARID2 homozygous (-/-) from JM8 mouse ESCs. Short RNA 
was purified using a single step method with RNAzol. (D) Northern blotting in ES-ERT2 (Ring1B  
knockout) cell line. Short RNAs were measured over a three day time course with and without 
(control) addition of tamoxifen. Short RNAs have a size of around 200 nt in Hes5 and Ybx2, and 
around  90  nt  for  Msx1.  Therefore,  production  of  short  RNAs  is  independent  of  polycomb 
repressive activity. 5S rRNA was used as a loading control. 
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To measure whether polycomb loss resulted in derepression of these short RNA-
producing genes, mRNA expression was measured at these genes by qPCR (Figure 9A 
and B). RNA was reverse-transcribed using oligo-dT primers and qPCR performed with 
primers that spanned an intron. It was found that none of the genes were upregulated 
upon  loss  of  EZH2  and  only  Msx1  increased  expression  upon  loss  of  Ring1B. 
Therefore, short RNA production remains constant even upon gene derepression caused 
by  loss  of  polycomb  binding.  This  means  that  the  short  RNAs  act  upstream  of 
Polycomb activity and are not a by-product of the repressive state it maintains.  
To  verify  that  short  RNA  expression  remains  constant  even  if  loss  of 
Polycomb activity causes mRNA  induction, expression data (Shen et al., 2008)  was 
sought to identify genes that  are derepressed  after  Ezh2  deletion. Pax3  increases in 
expression  in Ezh2-1.3. Northern blotting shows that short RNA remains constant in 
Ring1B  knockouts  (Figure  9C). Therefore, even at genes that are upregulated upon 
polycomb loss, short RNA production remains constant. It can be concluded from these 
experiments that PRC1 and PRC2 does not function to regulate short RNA production 
at polycomb target genes. Also, microarray data could have been compared with ChIP-
Seq data to identify polycomb target genes that are up-regulated upon Ezh2 and Ring1 
deletion  before  conducting  the  experiments  to  select  only  for  genes  that  polycomb 
targets and which are derepressed upon polycomb removal. 	 ﾠ 82	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Figure  9:  mRNA  expression  at  genes  producing  short  RNAs.  (A)  Quantitative  PCR  to 
measure changes in mRNA levels in the genes Hes5 (grey), Ybx2 (white), and Msx1 (black) in 
Ezh2-1.3 cells upon knockout of the polycomb Ezh2 subunit  of PRC2. Measurements were 
performed during a 5-day treatment with tamoxifen. Messenger RNA levels were normalised to 
Actin and to the time zero control. (B) Quantitative PCR for measurement of mRNA in ES-ERT2 
cells before and after addition of tamoxifen to induce deletion of Ring1b, showing that only Msx1 
is upregulated. (C) Northern blotting for short RNA transcribed from Pax3, which is derepressed 
in Ring1B knockout cell lines. 
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3.2.4 Short RNAs are lost from polycomb target genes active in other cell 
types  
Evidence  from  our  laboratory  indicates  that  short  RNAs  might  bind  to  the 
PRC2  complex.  If  short  RNAs  are  necessary  for  Polycomb  repression  one  might 
expect that loss of Polycomb gene activation is accompanied by loss of short RNAs. 
Gene  Ontology  describes  the  function  of  genes  and  the  relation  between  them.  To 
assess a possible correlation between transcriptional states and short RNA, we made 
use of the fact that many PRC-targeted silent genes in T-cells have a neuronal function 
using Gene Ontology analysis (performed by Aditi Kanhere). Therefore,  predictions 
were  made  for  genes  repressed  in  T-cells  but  active  in  neurons  using  gene 
expression data in T-cells (in house data) and looking at the function of the gene. 
RNA  from  the  neuroblastoma cell  line  SH-SY5Y  was used in  northern 
blots to look for the absence of short RNAs at genes silent in T-cells and active in 
neurons. As expected, the neuronal genes FOXN4, HEY1, MARK1, NKX2-2, BSN and 
HES5 show short RNAs in PBMCs but in the SH-SY5Y neuronal cell line these are 
reduced (Figure 10A). On the other hand, short RNAs are expressed at equal levels in 
both PBMCs and neuroblastoma cells for the genes YBX2 and NKX2-1, which are 
silent  in  both  cell  types.  These  results  suggest  that  short  RNAs  are  indeed  a 
characteristic of Polycomb-silenced genes. 	 ﾠ 84	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To observe the loss of short RNA during gene activation in a dynamic system, 
murine ES cells were differentiated into motor neurons (MN) (by Warren Whyte in 
Rick  Young’s  lab)  by  addition  of  retinoic  acid  (RA)  into  embryonic  bodies  (EB) 
(Wichterle et al., 2002). Hes5 and Pcdh8 are repressed in ESCs but activated in MN 
as confirmed by the increase in mRNA levels analysed by quantitative reverse-PCR 
(qPCR) (Figure 10B). Using northern blotting, it was found that short RNAs gradually 
decrease as  the  genes  are activated (Figure 10C). For Hes5, the progressive loss of 
the ~190 nt RNA is accompanied by the appearance of smaller RNAs, suggesting that 
there  is  degradation  of  the  short  RNA. Supporting  these  results,  our  laboratory has 
shown  that  short  RNAs  interact  with  PRC2,  hence  depletion  of  short  RNAs  could 
destabilise  the  association  of  PRC2  with  chromatin  allowing  gene  activation.  It  is 
interesting to note that gene activation during differentiation was coupled to a loss of 
short RNAs (Figure 10C) but gene activation (of Msx1 and Pax3) due to polycomb 
deletion was not (Figure 8B and D). Therefore, perhaps short RNAs may only disappear 
upon natural physiological cell differentiation processes. 
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Figure 10: Loss of short RNAs upon gene activation. (A) Northern blotting for short RNAs at 
the neuronal genes FOX4, HEY1, NKX2-1, MARK1, BSN, and HES5. These genes are active in 
SH-SY5Y neuronal cell line, and repressed in PBMCs. YBX2 and NKX2-1 are repressed in both 
cell types, and were used as controls. P – Peripheral blood mononuclear cells (PBMCs); N – 
SH-SY5Y neuronal cell line. (B) Quantitative PCR showing increased levels of transcription of 
Hes5 (grey) and Pcdh8 (white) during ES cell differentiation to motor neurons. Primers were 
designed at the 3’ end of each gene. mRNA levels were normalised to Actin. EB, embryoid 
bodies (day 2); EB+RA, EB treated with retinoic acid (day 2, 8 hours later); NPC, neuronal 
precursor cells (day 3), PMN, motor neuron precursors (day 4); MN, motor neuron (day 7). (C) 
Northern blotting for short RNA from Hes5 and Pcdh8, which become  activated during the step-
wise 4-day   differentiation to PMN.(D)	 ﾠDensity	 ﾠof	 ﾠthe	 ﾠmajor	 ﾠband	 ﾠon	 ﾠthe	 ﾠnorthern	 ﾠblots	 ﾠof	 ﾠfigure	 ﾠ10C.	 ﾠData	 ﾠ
was	 ﾠanalysed	 ﾠusing	 ﾠthe	 ﾠsoftware	 ﾠTotalLab	 ﾠQuant.	 ﾠ
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3.2.5 Short RNAs are stable transcripts 
A previous report has shown that the RNAPII present at polycomb-target genes 
is phosphorylated at Ser-5 but not at Ser-2 (Stock et al., 2007). In order to demonstrate 
that  this  is  also  true  of  the  RNAPII  transcribing  the  short  RNAs,  CEM  cells  were 
treated with Flavopiridol (FLAV), an inhibitor of  P-TEFb  phosphorylation  of  Ser-2, 
and Actinomycin D (ACTD), which inhibits RNAPII initiation. It was first confirmed 
that  these  compounds  were  specific  for RNAPII  by  performing  qPCR  on RNAPII-
transcribed β-Actin 5’end mRNA using primers for the first exon and first intron, and 
RNAPIII-transcribed 5S rRNA, as well as via analysis of RNAPI-transcribed 18s and 
28S  rRNA  integrity  using  a  Bioanalyser, in which peaks at the corresponding sizes 
were observed (Figure 11A and B). To confirm that the drug treatment was efficient, 
expression of the activation marker CD69 was stimulated by PMA and Ionomycin. If 
the  drugs  are  inhibiting  the  transcription  of  mRNA,  then  the  cell  should  not  be 
capable of upregulating CD69. FACS analysis for stained CD69 confirms  that  drug 
treated  cells  show  a  drastic  reduction  compared  to  non-treated  cells (Figure  11C). 
Short  RNAs  were then  purified  from  control  and  drug-treated  cells  and  blotted  for 
NKX2-1 and YBX2. These two genes were chosen since previous experiments from the 
laboratory of Richard Jenner showed that they have a good short RNA signal in this cell 
line. Hypothesizing that short RNAs are products of initiated but not fully-elongating 
RNAPII, no changes were expected in short  RNA expression in Flavopiridol treated 
cells, and reduced expression in Actinomycin D treated cells. However, short RNAs 
were  still  found  to  be  expressed  (Figure  11D)  after  treating  the  cells  with 
Actinomycin D. These results indicate that short RNAs are stable transcripts and that 
such types of analyses may not be suitably informative for RNAPII phosphorylation 
state. It is postulated that RNAPII is the polymerase most likely responsible for short 
RNA transcription, considering its presence at polycomb target genes (Kanhere et al., 
2010; Stock et al., 2007). However, these results also open the possibility that short 
RNAs are rather transcribed by RNAPIII or RNAPI.  
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Figure 11: Effect of inhibition  of  RNAPII transcription  on short RNA transcription. (A) 
Bioanalyser traces showing integrity of RNA extracted from CEM cell treated with Flavoporidol 
(top),  Actinomycin  D  (middle),  and  no  drug  control  (bottom).  (B)  Quantitative  PCR  showing 
reduced  levels  of  β-Actin  nascent  RNA  relative  to  5S  rRNA  in  drug-treated  cells.  Flav  – 
Flavopiridol;  ActD  –  ActinomycinD.  (C)  FACS  analysis  of  percentage  of  control  and 
PMA/Ionomycin stimulated CEM cells   expressing the T-cell receptor CD69. Upon inhibition of 
RNApII with Flavopiridol (Flav) and Actinomycin D (ActD) the cells cannot efficiently produce 
CD69.  (D)  Northern  blotting  for  short  RNA  in  CEM  cells  treated  with  Flavopiridol  (Flav), 
ActinomycinD (ActD), and control with no drug. NKX2-1 and YBX2 genes are repressed in the 
CEM cell line. 
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3.3 Discussion 
3.3.1 Short RNAs are transcribed in the absence of Polycomb 
When  levels  of  H3K27me3  or  H2Aub  are  lost  by  knocking-out  their 
respective catalytic proteins, short RNAs transcribed from these repressed Polycomb-
target genes remain unchanged. This occurs even when PcG knockdown results in de-
repression of some PRC targeted genes. Since Hes5 and Ybx2 do not show an increase 
in  mRNA  expression  upon  Ring1B  knockout,  and  Hes5,  Ybx2  and  Msx1  are  not 
upregulated upon Ezh2 knockout, ChIP-qPCR could have been used to confirm that 
these genes are polycomb targets. The reason the three genes did not behave in the same 
way  upon  polycomb  knockout  could  be  due  to  different  physiologic  characteristics, 
such as lack of activators for Hes5 and Ybx2, or RNA might be transcribed from these 
genes upon polycomb knockout, but not be fully processed. Regarding the use of Pax3 
to confirm short RNA expression upon mRNA up-regulation upon polycomb knockout, 
ChIP-qPCR could have been performed to confirm Ezh2 binding at Pax3.   
JARID2 is probably involved in PRC2 recruitment and according to Landeira et 
al. (2010) it is also involved in the recruitment of S5P RNAPII. However, JARID2 
knock down does not completely abolish S5P RNAPII recruitment, hence the presence 
of short RNAs in JARID2 knock down cells is expected. In constrast, genes which are 
naturally activated during ES cell differentiation into motor neurons exhibit depletion 
and even degradation of short RNAs. This indicates that their invariance upon Ezh2 
and Ring1 loss does not merely reflect their stability. Furthermore, this suggests that 	 ﾠ 89	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cell differentiation is associated with specific signals or transcription factors that lead to 
reduction in short RNA; in contrast, merely removing polycomb components does not. 
Another curiosity relies on the mechanisms that lead to short RNA degradation, which 
due to its apparent stability could be due o the action of exosomes. There is no certainty 
that these short RNAs are produced in the absence of longer RNA forms and they might 
instead  result  from  breaking  down  of  a  long  nascent  RNA  molecule.  Accordingly, 
Brookes et al. (2012) showed that PRC targets, which are highly interlinked with S5P 
RNAPII, produce transcripts that do not mature into mRNA. 
Considering  that  PRC2  interacts  with  RNA,  short  RNAs  might  function 
upstream  of  Polycomb,  stabilizing  the  association  of  PRC2  with  chromatin.  Short 
RNAs  could  act  like  the  ncRNAs  HOTAIR,  Xist, (Pandey et al., 2008; Rinn et al., 
2007; Zhao et al., 2008), and other large intergenic non-coding (linc) RNAs, a group a 
RNAs containing more than 3300 members of which 20% associate with PRC2 and 
are required for its repression (Khalil et al., 2009). Moreover, the polycomb  protein 
Cbx7  also  interacts with  chromatin  in  an  RNA-dependent  manner (Bernstein et al., 
2006a). ANRIL is an antisense RNA from the Ink4a/Arf locus that binds to the Cbx7 
protein (Yap et al., 2010). Indeed, the interaction of the newly identified short RNAs 
with  PRC2  has  been  confirmed  in  our  laboratory.  Xist  is  a  ncRNA  involved  in  X 
chromosome  inactivation  through  PRC2.  It  possesses  a  repetitive  element  named 
RepA that has a double-stem loop structure which has been found to directly interact 
with  PRC2  (Zhao  et  al.,  2008).  Structural  analysis  of  the  short  RNA  in  our 	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laboratory indicated that similar to the RepA element, these short RNAs also form a 
double stem-loop structure which is required for the PRC2 binding in vitro. The exact 
mechanism  by  which  these  short  RNAs  affect  Polycomb-chromatin  interaction  is 
currently unclear, but the RNAs could possibly function in the interaction of PRC2 with 
its target loci. 
 
3.3.2 Short RNAs are stable transcripts 
Repressed polycomb-target genes contain bivalent chromatin, have RNAPII 
associated  with  their  promoter  region  and  produce  short  RNAs,  indicative  of 
expression  regulated  at  the  level  of  transcription  elongation.  Stalled  RNAPII  is 
phosphorylated  at  Ser-5  only,  while  Ser-2  phophorylation  of  the  RNAPII  CTD 
(hyperphosphorylated  RNAPII)  is  required  for  a  productive  elongation.  Genes 
targeted by polycomb exhibit S5P RNAPII only (Stock et al., 2007). In an attempt to 
demonstrate that short RNAs are transcribed by RNAPII phosphorylated at Ser-5 but 
not at Ser-2, cells were treated with Flavopiridol, which inhibits Ser-2 phosphorlation 
only, or Actinomycin D, which inhibits RNAPII initiation. I found that upon total 
inhibition of RNAPII, short RNAs did not disappear. It is therefore likely that these 
short RNAs are stable transcripts. The fact that the short RNAs are detected even 
though they are not associated with actively transcribing polymerase is reflective of 
their stability. It would be also interesting to analyze the presence of the short RNAs 
upon knock-down of PcG members or look at the drug treated short RNAs during 	 ﾠ 91	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cellular differentiation.	 ﾠChIP	 ﾠcould	 ﾠalso	 ﾠhave	 ﾠbeen	 ﾠperformed	 ﾠto	 ﾠdetect	 ﾠthe	 ﾠdifferent	 ﾠstates	 ﾠ
of	 ﾠRNAPII.	 ﾠ It is currently unclear as to how these short RNAs are generated. They 
might be products of RNAPII stalling or derived from broken unspliced long RNAs, 
which is a possibility supported by the fact that Kapranov and colleagues have been 
able to identify overlapping long and short RNAs (Kapranov et al., 2007). 
 
 
3.4 Summary of Chapter 3 
 
1) Short RNAs are transcribed from polycomb target genes in murine ES cells in 
addition to human T-cells. Consequently, they are likely to be a general feature of the 
mammalian transcriptome. 
 
2)  Production  of  short  RNAs  is  independent  of  Polycomb  activity,  indicating  the 
possibility that they may function upstream of PRC2. 
 
3) Short RNAs are depleted from genes in cells where those genes are active, and 
this can be observed as a dynamic process when genes become activated through cell 
differentiation. This suggests that they might function in PcG mediated repression. 
 
 
4) Short RNA levels are not affected by inhibition of RNAPII by Actinomycin D. 
This either implies that they have a long half-life, or are transcribed by RNAPIII or 
RNAPI. 
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Chapter 4 - The role of short RNAs in polycomb response 
element function 
 
4.1 Introduction 
  The mammalian genome produces thousands of transcripts most of which are 
non-coding  RNA.  Beside  the  extensively  studied  interactions  of  polycomb  elements 
with lncRNAs, small RNAs have also been linked to PcG-mediated repression. It has 
been demonstrated that, in Drosophila, polycomb requires RNA interference (RNAi) to 
function (Grimaud et al., 2006a). Other non-micro-RNAs were identified at polycomb-
target genes that we designated short RNA and which seem to be a common feature 
among  higher  order  organisms.  Given  that  short  RNAs  are  transcribed  upstream  of 
polycomb  recruitment,  they  bind  PRC2  (Kanhere  et  al.,  2010)  and  that  they  get 
degraded as polycomb repressed genes become activated, short RNAs might have a 
function  related  with  polycomb  recruitment.  Although  Polycomb  response  elements 
(PREs)  have  been  identified  and  characterized  in  Drosophila,  evidence  for  their 
presence in mammals has been lacking. This is due to the fact that PcG-binding is not 
a critical factor to determine a PRE sequence. The PcG protein Pho is consistently 
associated with Drosophila PREs, yet the presence of its consensus sequence is not 
enough to define a PRE. The same is true for its mammalian homolog YY1, which is a 
multi-functional protein that interacts with several regulators including EED and BMI1. 
In Drosophila some PREs were correctly identified based on DNA-binding motifs, but 
such were absent in mammalian sequences. Therefore, new features must characterise 
PREs in mammals. A newly identified human PRE, designated HOXD11.12, revealed 	 ﾠ 93	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some  striking  similarities  with  the  chromatin  regions  around  the  short  RNAs  our 
laboratory identified. Such similarities include flanking H3K27me3 peaks (Kanhere et 
al., 2010) conserved regions within the PRE, a location at CpG-islands, and nuclease-
hypersensitivity  (Woo  et  al.,  2010).  Nucleosome  depletion  is  characteristic  of 
Drosophila PREs too, and is closely associated with the histone variant H3.3, which is 
more easily disassembled. These shared features suggest that short RNA transcription 
sites might function as PREs, and that this may be due to the interaction of short RNAs 
with PRC2. The microarray that Jenner used to identify short RNAs was limited to 
regions around protein-coding gene start sites. HOXD11.12 is located in between the 
HOXD11 and HOXD12 genes and is not represented on the array. Therefore, it was 
unknown whether short RNAs are transcribed from HOXD11.12.  
It  is  well  established  in  Drosophila  that  PRE  can  act  as  a  TRE  (Trithorax 
response element), thus the sequence having a dual function (Chang et al., 1995; Tillib 
et  al.,  1999).  Furthermore,  they  have  the  potential  to  switch  states  between  them 
(Beuchle  et  al.,  2001;  Cavalli  and  Paro,  1998,  1999;  Klymenko  and  Muller,  2004). 
Some of the factors used to construct the algorithm that predicts PRE/TRE participate in 
both activation and repression such as Zeste, Gaf and Pipsqueak (Decoville et al., 2001; 
Dejardin  and  Cavalli,  2004;  Hagstrom  et  al.,  1997;  Huang  et  al.,  2002).  Another 
relevant point is the involvement of a ncRNA enconded by the PRE/TRE bithoraxoid 
(bxd) in the recruitment of the methyltransferase ASH1 to activate Ultrabothorax (Ubx) 
gene expression (Sanchez-Elsner et al., 2006). A lncRNA transcribed from the 5’ end of 
the HOXA locus called HOTTIP, also interacts with WDR5-MLL complex to induce 
H3K4 trimethylation and HOXA activation (Wang et al., 2011). 	 ﾠ 94	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4.2 Results   
4.2.1 Short RNAs are transcribed from the HOXD11.12 PRE 
Comparing the data from our laboratory to that published by Woo et al (2009), 
such  similarities included an identical pattern of H3K27me3 distribution, high CpG 
content, and low nucleosome occupancy (analysed by Aditi Kanhere). This evidence 
has led to the hypothesis that short RNAs might be transcribed from PRE elements 
and  that  these  are  responsible  for  PRE  activity.  A  closer  look  at  the HOXD11.12 
region  on  the  UCSC  Human  Genome  Browser  re-enforced  this  hypothesis  by 
revealing the presence of a TSS located between the two H3K27me3 peaks (Figure 12). 
Woo  et  al  (2009)  identified  the  Polycomb  recruitment  activity  of  the 
HOXD11.12  PRE  in  ES-cell  derived  mesenchymal  stem  cells  (MSC),  where  the 
HOXD11 and HOXD12 genes are repressed. The similarities between our short RNA 
transcription sites and the HOXD11.12 PRE lead to the question of whether short RNAs 
are also transcribed in HOXD11.12. To this end, an immortalised MSC line derived 
from bone marrow  was used  (Funes et al., 2007). This cell line has a different 
origin to those used by Woo et al. (2010), which are derived from H1 and H9 human 
ESCs.  Chromatin  immunoprecipitation  with  antibodies  against  H3K4me3,  and 
H3K27me3 was performed followed  by  qPCR analysis to verify that HOXD11.12 is 	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also  targeted  by  polycomb  in  these  cells  (Figure  13A).  However,  given  the  low 
enrichment of H3K27me3, it would have been useful to perform ChIP-qPCR for PRC2 
to ensure that this gene is being targeted by polycomb. 
Given the resemblance of the HOXD11.12 PRE to the short RNA loci we had 
identified, we hypothesized that the mammalian PRE might also produce short RNAs. 
To test this, fifteen probes, ≤ 100 nucleotides apart, were designed across the entire 
HOXD11.12 region. Northern blotting with these probes revealed that short RNAs are 
transcribed  from  HOXD11.12  around  the  alternative  HOXD11  TSS  (Figure  13B). 
These RNAs are about 20 to 30 nucleotides long and occupy a region 150 nucleotides 
long. Short RNA bands can also be observed at the control gene HOXC6 in MSCs, 
shown by our laboratory to be repressed and to produce short RNA in T-cells, and 
enriched for H3K27me3 in MSC (Woo et al., 2010). These results reveal that short 
RNAs are transcribed from the HOXD11.12 PRE in MSCs. 
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Figure 12: Analysis of short RNAs transcribed from HOXD11.12. (A) Secondary structure 
derived  from  the  RepA  ncRNA  (top)  used  to  identify  similar  structures  within  short 
RNAs.Predicted secondary structures found in short RNAs transcribed from the D11.12 PRE 
(bottom). (B) Localisation of the HOXD11.12 PRE and the sequences with predicted double 
stem-loop structures for short RNAs 1 and 2 at the UCSC genome browser. HOXD11.12 is 
localised between H3K27me3 peaks (top panel; from Woo, 2010) and contains an alternative 
TSS for HOXD11 (bottom panel). The short RNAs are situated on a CpG island.  
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Figure 13: Detection of short RNAs transcribed from HOXD11.12. (A) Quantitative PCR for 
detection of H3 (black) H3 K4me3 (grey) and H3K27me3 (white). β-Actin was used as control. 
HOXC8 is repressed in wild type Mesenchymal Stem Cells but not in carcinogenic transformed 
(5hit) mesenchymal stem cells (Funes JM et al. 2007). DNA levels were normalised to H3. (B) 
Northern  blotting  detecting  short  RNAs  at  the  HOXD11.12  PRE.  15  probes  were  designed 
spanning the entire HOXD11.12 sequence (top panel). HOXC6 is repressed in T-cells (PBMCs 
and CEM) and in MSCs and was used as a positive control. 
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4.2.2 HOXD11.12 short RNAs contain stem-loop structures and are located 
at a CpG island 
The  PRC2  binding  site  within  mouse  Xist  RepA  is  a  double  stem-loop 
structure  that  is  repeated  7  times  (Figure  12A)  (Zhao  et  al.,  2008).  Moreover,  the 
novel  short  RNAs  identified  in  our  laboratory  also  have  the  potential  to  form  this 
structure. For this reason, the short RNAs identified in HOXD11.12 were examined 
to find whether they could also form the same structure. A general structural motif 
was  derived  based  on  the  RepA  sequence,  and  RNAmotif  was  used  to  detect 
sequences that would produce this structure in the immediate surroundings of probes 
number 7 and 8, and could fold into a double stem-loop structure, and to confirm 
the free-energy values for these structures were under -6.5kcal/mol. Two ~30 nt  long 
sequences with predicted double stem-loop were identified (Figure 12A). 
Furthermore, it has been shown that PcG proteins localise to CpG islands (Ku 
et al., 2008), and that these islands might be important for Polycomb recruitment. Sites 
of  short  RNA  transcription  were  also  commonly  associated  with  CpG  islands. 
Consistent with this, the HOXD11.12 short RNAs are also transcribed from a CpG 
island  (Figure  12B).  These  results  indicate  that  short  RNAs  transcribed  from 
HOXD11.12 PRE have the potential to interact with PRC2. 
 
4.2.3 Role of short RNAs in HOXD11.12 PRE activity 
Given  the  presence  of  short  RNAs  in  HOXD11.12,  I  sought  to  determine 
whether  these  short  RNAs  are  required  for  HOXD11.12  PRE  activity.  To  this  end, 
HOXD11.12 was cloned into a luciferase reporter vector that contains an YY1 region 
and a promoter from the TATA box of Herpes simplex virus thymidine Kinase (pYY1-
Luc) as performed by Woo et al. (2009). In addition, mutations in HOXD11.12 were 	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generated; deleted conserved region (marked by the green box in Figure 14A), deleted 
short RNA region (marked by the red box in Figure 14A) and disrupted RNA secondary 
structure with point mutations (Figure 14B), in order to allow the significance of these 
DNA sequences in PRE activity to be assessed. The UCSC genome browser was used 
to design primers that would amplify the sequences upstream and downstream of the 
region to be deleted and the halves then ligated together. Site directed mutagenesis was 
used to disrupt the short RNA structure, by designing primers that align at the mutated 
region and have no-overlapping much longer than the pp region of the primers. This 
allows for amplification of the mutated plasmid in a single step. The vectors were then 
transfected  into  MSCs  produced  by  Funes  et  al.  (2007).  Measurement  of  luciferase 
activity  revealed  that  the  HOXD11.12  insert  in  the  pYY1-Luc  vector  did  not  have 
repressive activity in MSCs, despite the fact that the endogenous region is trimethylated 
at H3K27 (Figure 15A). However, H3K27 trimethylation was only 2-fold enriched and 
this might be a reason why no repressive activity was observed. The conditions of MSC 
cell  culture  were  altered  in  an  attempt  to  induce  cellular  differentiation  into 
chondrocytes and observe possible changes in gene expression. To this end, MSCs were 
transfected in high and low confluency and for each of these conditions transfection 
from cells that grew with serum and another set without added serum was performed. 
Chondrocytes are formed when MSCs are left at high confluency with no added serum 
(Augello and De Bari, 2010), therefore results could be compared between induced 
chondrocytes and MSCs. In none of these conditions did HOXD11.12 exhibit repressive 
activity (Figure 15B). In an attempt to identify a cell type in which the HOXD11.12 
sequence has a repressive activity, I experimented transfecting it into other cell types – 
Hela and SH-SY5Y. Again, in both cell lines exogenous HOXD11.12 failed to repress 
the  reporter  gene.  In  fact,  all  these  cell  types  HOXD11.12  rather  has  an  activatory 
effect, acting instead like a Thritorax response element (TRE).  
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Figure  14:  Constructs  for  assessment  of  features  in  HOXD11.12. (A) – UCSC genome 
browser representation of HOXD11.12, located at the alternative TSS of HOXD11. The green 
box indicates the part of the conserved region that was deleted; the red box indicates a second 
deleted region from  which  short  RNAs  were  detected  (black  bar).  (B) –  DNA sequences in 
HOXD11.12  near  probe  7  and  8  (first  and  second  short  RNAs)  with  normal  sequence  and 
respective secondary structure, and with mutated sequences and respective disrupted double-
stem  loop  structure;  the  stem-loop  structures  were  predicted  by  RNAfold.  (C)  –  Schematic 
representation of the vectors used for the luciferase assay. The black box represents the YY1 
enhancer element, the green arrow indicates the site of deletion of the conserved region, the 
red arrow indicates the region of deletion of the short RNA sequence, the two black arrows 
indicate the point mutation for disruption of the secondary structure of the short RNAs. 
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Figure  15:  Activity  of  HOXD11.12  PRE/TRE.  (A)  Luciferase  expression  in  percentage  of 
Relative  Light  Units  (RLU  %)  from  a  vector  containing  one  of  the  potential  PRE  D11.12 
upstream of the promoter, measured in transformed mesenchymal stem cells (MSCs, 5 hit; 
Funes  JM  et  al.  2007),  Hela,  and  the  neuronal  cell  line  SH-SY5Y.  ∆ConsD11.12, 
∆shortRNAD11.12, and ∆shortRNAstructD11.12 respectively correspond to D11.12 sequence 
with  deleted  conserved  region,  D11.12  sequence  with  deleted  shortRNA  region,  and  with 
mutation of the shortRNA region that disturbs the double stem loop structure.  PLuc (-), and 
YY1pLuc (+) represent the negative and the positive controls, respectively. RLU is normalized 
so that pLuc(-) is 1% and pYY1Luc(+) is 100%, according to the method of Woo et al. (1), (2), 
and (3) represent independent clones. (B) Luciferase expression in percentage of Relative Light 
Units (RLU %) from a vector containing the HOXD11.12 sequence upstream of the promoter, 
measured in transformed MSCs. Clone details as in (A). Cells were placed in several condition: 
low  confluency  with  serum  (white),  low  confluency  without  serum  (starving;  light  grey),  high 
confluency with serum (dark grey), and high confluency starving (black).  
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4.2.4 Other short RNA loci can potentially behave as PREs 
HOXD11.12 shares similarities with the short RNAs regions identified in our 
laboratory,  as  described  on  section  4.2.1.  These  regions  include  the  two  flanked 
H3K27me3  peaks  with  short  RNAs  in  the  centre,  and  which  contains  a  TSS.  The 
regions analysed here correspond to HOXD11.12, YBX2, RASL12, and MSX1. To 
confirm that these DNA sequences similarly to HOXD11.12 have repressive activity, 
they were cloned into the pYY1Luc as before and individually transfected them into the 
MSCs, Hela, and SH-SY5Y cells. Not every sequence was repressive in every cell type 
(Figure 16A). MSX1 was not repressive in any of the cells used and instead had an 
enhanced activity in MSC and Hela. RASL12 was repressive only in SH-SY5Y, and 
YBX2 was repressive in Hela and SH-SY5Y. Again, different conditions of MSCs cell 
culture  were  tested  to  see  if  it  would  have  any  effect  on  luciferase  activity  by 
stimulating chondrocytes formation. MSX1 failed to gain repressive activity in serum-
starved, high confluence cells and there was also little effect on  the two other potential 
PREs, RASL12 and YBX2 (Figure 16B). In an attempt to determine whether the MSX1 
short RNA loci could be repressive, cell types were analyzed for MSX1 that has high 
levels  of  H3K27me3  using  the  UCSC  genome  browser.  MSX1  was  positive  for 
H3K27me3 in H1-ES cells and NHEK (Figure 17A), meaning that this cell line could 
be a good cell line to try this transfection.  	 ﾠ 103	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Figure  16:  Potential  PRE  activity  of  other  short  RNA  loci. (A) Luciferase expression in 
percentage of Relative Light Units (RLU %) from a vector containing one of the potential PRE 
MSX1, RASL12, and YBX2 upstream of the promoter, measured in transformed MSCs (5 hit; 
Funes  JM  et  al.  2007),  Hela,  and  neuronal  cell  line  SH-SY5Y.  PLuc  (-),  and  YY1pLuc  (+) 
represent  the  negative  and  the  positive  controls,  respectively.  (1),  (2),  and  (3)  represent 
potential PRE sequence obtained from different clones. (B) Luciferase expression in percentage 
of  Relative  Light  Units  (RLU  %)  from  a  vector  containing  one  of  the  potential  PRE  MSX1, 
RASL12, and YBX2, measured in transformed MSCs,. PLuc (-), and YY1pLuc (+) represent the 
negative  and  the  positive  controls,  respectively.  Cells  were  placed  in  several  condition:  low 
confluency containing serum (white), low confluency with no serum (starving; light grey), high 
confluency with serum (dark grey), and high confluency starving (black). 
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Figure  17:  Trimethylation  levels  in  different  cell  types. (A) - H1ESC (green) and NHEK 
(pink) cells have high levels of H3K27me3 on the MSX1 gene. (B) – H1ESC (green), HUVEC 
(orange), and NHEK (pink) cells have high levels H3K27me3 on HOXD11.12.  Both figures 
were generated and data extracted from the UCSC genome browser. The y-axis represents 
number of reads. 
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4.3 Discussion 
4.3.1 Short RNAs are transcribed from the HOXD11.12 polycomb response 
element 
PRE  elements  are  regulatory  sequences  are  defined  as  being  necessary  and 
sufficient for the recruitment of PcG proteins. Identification  of PREs in Drosophila 
had proven difficult due to the lack of sequence homology, apart from the presence of 
the consensus Pho/YY1 binding sites. Eventually, the identification of several PRE-
binding  DNA-binding  proteins,  such  as  Pho  allowed  the  construction  of  PRE 
prediction algorithms in Drosophila.  Unfortunately, apart from the mammalian non-
functional homologue of Pho, YY1, there are no known mammalian homologues for 
these  factors.  However,  short  RNAs  transcribed  from  polycomb-targeted  genes  in 
mammals bind to PRC2 and thus may mediate PRC2 recruitment. 
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Recently,  two  mammalian  PREs  have  been  identified,  one  in  mice  and  the 
other  in humans. Surprisingly, there is no conservation of the YY1 binding site in the 
mouse PRE-kr. There  are  though  a  few  similarities  between  the  Drosophila  PREs 
and  the  newly  found  human  HOXD11.12  PRE.  These  include  nucleosome 
depletion, and high sequence conservation across species. The loci surrounding short 
RNAs produced from mammalian Polycomb targets share all these common features 
and are also located on CG rich regions, implicated in PRC2 recruitment in mammals. 
CpG islands and nucleosome-free areas have a relative overlap, which might mean that 
CpG  di  nucleotide  frequency  contributes  to  the  absence  of  nucleosomes,  perhaps 
because these sites are frequently sites of transcription initiation. Moreover, nucleosome 
depletion is conserved from Drosophila to humans indicating its importance, probably 
for the recruitment of proteins. 
 Similar  between  HOXD11.12  and  the  short  RNA  loci  identified  in  our 
laboratory,  was  the  H3K27me3  distribution  pattern  around  the  TSS,  which  was 
identical  between  the  HOXD11.12  sequence  and  DNA  sequences  from  where  the 
short  RNAs are  transcribed.  Furthermore,  analysis on  the  UCSC  browser  revealed 
that  just  as  short  RNAs  are  transcribed  from  the  5’  region  of  target  genes, 
HOXD11.12 also contains an alternative TSS for HOXD11, which lies in between the 
two H3K27me3 peaks.  Although  some  Drosophila PREs  are  located  far  from  the 
promoter  region  in the HOX cluster, most are located at TSS (Oktaba et al., 2008; 
Schwartz et al., 2006). 
Given the similarities between HOXD11.12 and our short RNA regions, it is 
possible that HOXD11.12 also produces short RNAs. Using northern blotting, found 
that this was indeed the case. Some RNAs such as Xist, HOTAIR and Kcnq1ot1 bind 
to PcG proteins. Short RNAs identified in our laboratory have double stem-loops that 	 ﾠ 106	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also interact with PRC2. RNAs from the HOXD11.12 PRE have a structure similar to 
that of the RepA subunit of Xist, which also binds to PRC2, thus indicating a potential 
similar function for the HOXD11.12 short RNAs. 
 
4.3.2 Activity of potential PREs and TREs 
As mentioned above, HOXD11.12 shares a few similarities with the short RNA 
loci identified in our laboratory including the fact that HOXD11.12 also produces short 
RNAs.  This  lead  to  the  question  of  whether  these  short  RNAs  are  required  for 
HOXD11.12 PRE activity. The transfection of the HOXD11.12pYY1Luc vector from 
Woo et al. (2010) into immortalised MSCs gave contradictory results compared to those 
obtained by that article. This is possibly due to the use of a different type of MSCs to 
that used by Woo; I used bone-marrow derived cells whereas Woo et al. (2010) used 
MSCs differentiated from H1 and H9 hESC. According to Young et al. (2011) there are 
three profiles of H3K27me3: 1) broad domains and these genes are silenced, 2) bivalent 
genes, that are also silenced, 3) narrow peaks at the promoter of active genes. It is 
possible that the HOXD11.12 behaves as the third profile of H3K27me3. It is also 
possible that endogenous and exogenous HOXD11.12 do not behave in the same way, 
hence, ChIP-QPCR for detection of H3K27me3 at the vector would be useful. It is also 
possible  that  given  that  the  HOX  clusters  are  involved  in  development  and 
differentiation, which are highly regulate by PcG, and cancer cells show changes in 
expression of PcG proteins (Alharbi et al., 2013; Cillo et al., 1995; Jin and Sukumar, 
2010), it is probable that transformed MSCs have changed expression pattern of HOX 
genes making it possible that the expression of alternative TSS of HOXD11 is altered. 
When attempting to use chondrocytes to analyze HOXD11.12 there are a couple of 
possible  reasons  for  the  negative  results.  One  is  that  chondrocytes  have  active 
HOXD11, the second is that MSCs did not properly differentiate into chondrocytes. To 
check for this last possibility, potential chondrocytes could have been stained for Alcien 	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Blue, a dye that stains sulfated proteoglycans deposits thus indicating the presence of 
functional  chondrocytes.  Given  that  the  vector  might  not  be  chromatinized,  an 
alternative to the method used would be integrating the vector into the genome, which 
could be accomplished by lentivirus infection or homologous recombination into gene 
deserts (Lienert et al., 2011). Although endogenous HOXD11.12 in MSCs seems to be 
repressed, its level of H3K27me3 is not very high. Therefore, it was reasonable to look 
in the UCSC genome browser for cell types where HOXD11.12 is marked by high 
levels of H3K27me3. I found that HOXD11.12 was highly positive for H3K27me3 in 
H1-ES, HUVEC and NHEK (Figure 17B) for which transfection of HOXD11.12 in 
these cells could be possible.  
Other cell types (Hela and SH-SY5Y) were transfected with the vectors in an 
attempt to identify other cellular environments in which the sequences behaved as PREs 
and repressed luciferase expression. YBX2 in Hela, and SH-SY5Y cells and RASL12 in 
SH-SY5Y  cells  have  repressive  effects  on  luciferase  expression,  meaning  that  they 
might indeed be mammalian PREs. Inversion of the PRE-kr leads to loss of its function. 
It would be interesting to check whether inversion of these potential PREs would have 
the  same  effect.  Other  relevant  experiments  would  be,  likely  what  was  done  in 
HOXD11.12, to delete the short RNA site in both YBX2 and RASL12 to analyze the 
relevance they have on PcG recruitment and following positive results to mutate these 
short  RNA  sequences  in  order  no  disrupt  double  stem-loop  structure  to  assign  its 
significance in PcG interaction. 
Unexpectedly,  HOXD11.12  has  an  activatory  effect  in  bone-marrow  derived 
MSCs,  Hela,  and  neuronal  SH-SY5Y  cells,  potentially  acting  like  a  TRE,  perhaps 
because the endogenous HOXD11.12 region is active in these cells. Indeed, a report 
shows that HOXD11 is expressed in motor neurons (Misra et al., 2009). In fact, the 
PRE sequence can reversibly switch between silencing and activation, also acting as a 
TRE (Beuchle et al., 2001; Cavalli and Paro, 1998, 1999; Klymenko and Muller, 2004). 
A  recent  study  suggests  that  the  switch  occurs  at  the  transition  of  direction  of 	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transcription of ncRNAs, making it possible that, besides the sense short RNAs we 
identified, there could also be antisense short RNAs (Herzog et al., 2014). Furthermore, 
it is not surprising that PRE can act as TRE as polycomb proteins generally associate 
with  promoters.  It  is  possible  that  like  Drosophila  PREs,  mammalian  PREs  can 
alternatively act as TREs in the absence of PRC binding. To confirm this possibility I 
would have to analyze the recruitment of proteins belonging to the Trithorax complex 
such as MLL and SET1.  
 
4.4 Summary of chapter 4 
1) Short RNAs are transcribed from the human HOXD11.12 PRE, suggesting that 
PRE function may be mediated by PcG-RNA interactions. 
 
2) D11.12 short RNAs present the same characteristics as previously identified short 
RNAs. They contain a potential double stem-loop structure, and are located within a 
CpG island. 
 
3) The HOXD11.12 PRE also possesses activatory function, depending on the cellular 
context, potentially acting as a TRE. 
 
4) The RASL12 and YBX2 short RNA loci are repressive in SH-SY5Y cells but not 
MSCs and Hela cells, whereas YBX2 is repressive in MSCs and Hela , but not SH-
SY5Y  cells.  This  demonstrates  that  the  repressive  effects  of  such  loci  is  cell-type 
specific.    	 ﾠ 109	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Chapter 5 - Conclusions 
 
As part of the work carried out for this thesis, investigations have been carried 
out regarding aspects of non-coding RNA transcription and the recruiting mechanism of 
Polycomb group proteins to their target regions. In order to best analyze purified and 
fractionated RNA, two different methods were compared: single step RNAzol, and two 
step  TRIzol/MiRvana  methods.  It  is  concluded  that  TRIzol/MiRvana  method  gave 
better quality RNA because use of RNAzol led to loss of ~ 200nt RNA species. 
Previously,  our  laboratory  observed  that  RNA  Pol  II  is  present  at  Polycomb 
target genes and that short RNA transcripts are present. This work has been extended to 
show  that  the  production  of  these  RNAs  is  conserved  across  species  as  they  are 
produced in human primary resting CD4+ T-cells and in mouse ESCs. By extension, 
this indicates there might be functional significance for these short RNAs. It has also 
been  successfully  demonstrated  that  such  RNAs  are  very  stable  by  observing  their 
presence in cells treated with RNAPII inhibitors. 
Polycomb proteins have no known DNA-binding sites and it is not clear how 
they target mammalian genes. A question asked was whether short RNAs produced at 
repressed polycomb targeted genes would also express these short RNAs when the gene 
was active. Therefore, in our laboratory, the production of short RNA from neuronal 
genes  was  compared  between  differentiated  SH-SY5Y  neuronal  cells,  where  these 
genes were active and PBMC cells were these genes were silenced by polycomb. It was 
observed that short RNAs were present only at genes in the cell type in which they were 
repressed  by  polycomb.  Furthermore,  differentiation  of  ES  cells  to  motor  neurons 
demonstrated a gradual loss of short RNAs as genes became activated. Hence there is a 
link  between  short  RNA  production  and  gene  activity.  On  these  lines,  it  became 	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important  to  test  whether  the  presence  of  short  RNA  was  a  mere  by-product  of 
polycomb silencing activity at these genes or whether they were produced upstream of 
polycomb activity.  Ezh2 and Ring1B knockout ESC lines were utilised to test and 
subsequently  verify  that  production  of  short  RNAs  at  this  repressed  genes  is 
independent of PRC activity. It is questionable whether the short RNAs are actually a 
product of longer RNA degradation. Not every gene begins mRNA expression upon 
polycomb  knockout,  a  phenomenon  not  currently  well-understood  and  possibly 
indicates the existence of different mechanisms of polycomb action, or some genes 
might not reactivate when deleted polycomb because the transcription factors necessary 
are nor present. 
Attempts were made to test whether short RNAs could be functional rather than 
just merely being waste products of RNAPII pausing. It was later further demonstrated 
in the laboratory that these short RNAs bind to the SUZ12 subunit, and have a double 
stem loop structure similar to the RepA motif in the Xist RNA, a structure that seems to 
be important for interaction with PRC2. It is important to make future in vitro (EMSA) 
and in vivo (RNA IP or Chip) experiments with mutations that disrupt the double stem 
loop  structure  to  draw  conclusions  regarding  the  importance  of  short  RNA  and  its 
specific secondary structure. 
Using  computational  algorithms  to  identify  specific  sequences  enriched  at 
polycomb target sites, it was possible to predict Drosophila PREs with some accuracy 
(Ringrose and Paro, 2004; Ringrose et al., 2003). Unfortunately, the same algorithms 
could not predict PREs in mammals due to lack of homologies between sequences. 
Therefore, different features must rule the determination of mammalian PREs. It was 
noticed that there are similarities between the identified short RNA regions and a newly 
identified  mammalian  PRE,  HOXD11.12.  Such  similarities  include  a  nucleosome-	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depleted region, a CpG island, high sequence conservation and flanking H3K27me3 
peaks. Given these reasons and similarities between the short RNA regions and the 
HOXD11.12 PRE, tests were carried out to determine whether this PRE also produces 
short RNAs, for which positive results were obtained. Overall, it is indicative that these 
five  features  might  constitute  typical  characteristics  of  a  mammalian  PRE.  The 
HOXD11.12 RNAs also have the potential to form a double-stem loop structure and 
hence  have  the  potential  to  interact  with  PRC2.  Further  analysis  of  the  activity  of 
HOXD11.12 showed that HOXD11.12 acts as an enhancer of expression in cells where 
HOXD11 is expressed. Therefore, this PRE could potentially also function as a TRE. 
Other DNA sequences (YBX2 and RASL12) with a series of characteristics identical to 
HOXD11.12, for which respective genes are repressed in those cells types, produce 
short RNAs and can potentially behave as a PRE. It is important to test whether PRC 
structures are present at these sites by ChIP-qPCR. The importance of these features is 
based on the facts that conserved region of HOXD11.12 is essential for abundance of 
polycomb proteins at the site; PRC2 is associated with CpG island, although it is not 
very well understood why, being possible that the reason is due to KDM2b binds to 
unmethylated DNA at CpG; furthermore, nucleosome depletion allows for accessibility 
of proteinic complexes. These features are associated with polycomb protein binding 
allowing for its repressive activity. 
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Chapter 6 - Future Research 
 
Although short RNAs are transcribed upstream of polycomb activity and that they bind 
to SUZ12, it has not been demonstrated that they are crucial for silencing of respective 
genes, nor that the DNA sequences comprising these short RNAs might be PREs. It is 
also unknown whether these short RNAs are transcribed by RNAPII phosphorylated 
only at Ser5. It is also of importance to analyze whether short RNAs are a product of 
polymerase stalling or derived from long RNA processing. A list of future studies to be 
carried out in order to answer relevant remaining questions are presented as follows: 
 
Experiments involving transcriptional analysis: 
 
1.  A  well-known  ncRNA,  Kcnq1ot1,  is  transcribed  from  the  antisense 
strand of the Kcnq1 cluster (Pandey et al., 2008). ANRIL is another antisense 
ncRNA identified (Yap et al., 2010). Additionally, thousands  of  novel  short 
RNAs mapped genome-wide are antisense to known genes (Kapranov et al., 
2010). Although  short  RNAs identified in  our laboratory are transcribed  from 
the  sense  strand,  this  evidence  indicates  there  is  a  probability  of  antisense 
RNA  being  transcribed  from  polycomb  target  genes.  Future  research  could 
therefore include designing northern probes to detect antisense long and short 
RNA at polycomb target genes. 
 
2.  Although  microarray  analysis  in  CD4+  T-cells  from  our  laboratory 
shows  that  short  RNAs  are  transcribed  from  silent  genes  (no  detected 
mRNA), this does not rule out the possibility of longer non-poly-adenylated 
RNA being transcribed from the same locus. Specifically, it is important to 	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understand  why  transcription  of  these  long  RNAs  is  not  associated  with 
H3K79me2 or H3K36me3. A plausible reason can be found in the explanation 
that  they  are  unspliced  RNAs  transcribed  by  Ser-5  phosphorylated  Pol  II 
(Hargreaves et al., 2009). It is possible that short RNAs are actually products 
from such unprocessed long RNAs. Supporting this idea is the overlap between 
novel long and short RNAs transcriptional fragments (Kapranov et al., 2007). 
Northern blotting for detection of long RNA could be performed to test whether 
there long RNA at this short RNA producing genes.  
 
3.  To prove that short RNAs are transcribed by RNAPII phosphorylated 
at Ser-5 only, CEM cells can be treated with drugs that inhibit P-TEFb from 
phosphorylating the Ser-2, for example, the drugs Flavopiridol and DRB. In 
parallel,  total  inhibition  of  RNAPII  initiation  can  be  accomplished  with 
Actinomycin D or Alpha-Amanatin. However, previous experiments revealed 
that  these  short  RNA  are  very  stable  as  northern  bands  persist  from  cells 
treated with Actinomycin D, and Amanatin. A new method is required which 
only  detects  new  transcripts.  To  address  this  issue,  new  RNA  transcripts 
could be evaluated by pulse-chase experiments using radiolabelled nucleotides. 
Therefore, only RNA newly transcribed after the addition of the drugs, would 
be detected by northern blotting. 
	 ﾠ
4.  To  test  whether  other  RNA  polymerases  might  transcribe  the  short 
RNAs, different RNA polymerases inhibitors should be tested with pulse-chase 
and compared. Thus, Flavopiridol and DRB do not inhibit RNAPII transcription 
initiation only, while Triptolide inhibits both RNAPII and RNAPI transcription 
initiation. On the other hand, Alpha-Amanitin inhibits transcription of RNAPII 
and RNAPIII but not RNAPI (Bensaude, 2011). 	 ﾠ 114	 ﾠ
 
5.  Short  RNA  is  degraded/depleted  upon  gene  activation  during 
neuronal  differentiation  but  not  when  polycomb  is  depleted.  RNA 
degradation can be achieved by ribonucleases, namely: endonucleases that 
cut RNA internally, 5′ exonucleases that hydrolyze RNA from the 5′ end, and 3′ 
exonucleases that degrade RNA from the 3′ end. A systematic knockdown of 
components  of  these  pathways  during  cell  differentiation  would  be  highly 
beneficial to observe and identify the exact pathway, which lowers H3K27me3 
levels. 
 
Experiments involving analysis of PREs: 
6.  For a sequence to function as a PRE, it would have to recruit 
Polycomb  proteins.  To  this  end,  ChIP  could  be  used  for  several 
polycomb  components,  with  subsequent  analysis  of  enrichment  by 
qPCR. 
 
7.  To  confirm  that  the  HOXD11.12  PRE  in  immortalised  MSCs  also 
confers  repressiveness,  this  PRE  was  cloned  into  a  luciferase  vector,  as 
performed by Woo et al. (2010). However, it was not possible to recapitulate 
the repressive effect of the HOXD11.12 sequence on luciferase expression in 
bone marrow derived MSCs in the present work.  Therefore, it may be that 
HOXD11.12 behaves differently in these cells compared to the ESC-derived 
MSCs used by Woo et al. and therefore using these cells may be required. 
Other  cell  types  containing  high  levels  of  H3K27  methylation  on  the 
HOXD11.12 region have been identified, and transfection of these cells may 
reveal that the HOXD11.12 sequence is repressive in these cell types. 
Another  promising  strategy  that  could  be  employed  is  the 	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performance  of  nucleofection  instead  of  tranfection  with 
electroporation,  given  that  it  allows  better  cell  viability  and 
transfection rates of up to 95% (Zeitelhofer et al., 2007). 
 
8.  In order to better examine the potential PRE sequences in a 
chromatinized state, the vector could be integrated into the genome 
by lentivirus infection or by homologous recombination into a gene 
desert or through the CRISPR technique described in Wilkinson and 
Wiedenheft (2014). 
	 ﾠ
9.  Our laboratory also showed that PRC2 binds to short RNA and that 
the  secondary  structure  is  fundamental  for  this  binding  in  vitro.  EMSA 
experiments using wild-type and mutated short RNAs in HOXD11.12 PRE 
would show whether this is also the case for the short RNA at this potential 
PRE. Cell extracts from Escherichia coli expressing recombinant PRC2 would 
be used for EMSA. 
 
10.  It would be also important to test if short RNAs at HOXD11.12 are 
important for PRE function in cells by showing that it binds to PRC2. To this 
end,  native  RNA  immunoprecipitation  for  SUZ12  could  be  carried  out  and 
checked for short RNA enrichment by qPCR. By constructing DNA mutations 
that lead to short RNA disruption, it would be possible to confirm if they are 
indeed important for PRC recruitment. Compensatory mutations that restore the 
RNA structure could then be introduced and checked for PRC2 binding and 
luciferase expression. 
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11.  A  characteristic  of  Drosophila  PcG  system  is  that  they  maintain 
repressive  states  as  the  cells  divide.  Woo  et  al.  (2010)  reported  that 
HOXD11.12  repressive  ability  could  be  heritably  transmitted  through  cell 
differentiation (Woo  et al., 2010).  This feature could also be tested  in  other 
short RNA loci by making use of the mESC’s differentiation to motor neurons. 
Genes  repressed  in  both murine  stem  cells  and  neurons,  such  as  NKX2-1 
and YBX2, could  be  used  for  such  analyses.  Pcdh8  becomes 
activated upon differentiation, and could be used as a positive control. This 
experiment  would  also  show  whether  short  RNA  transcription  from  PRE 
elements is a common feature between mice and humans. 
 
12.   PREs can also act as TREs. In order to analyse the TRE functionality, 
ChIP  for  Trithorax  proteins  (e.g.  MLL  and  SET1)  could  be  performed  in 
transfected cells showing high luciferase activity. By RNA IP in cell extract or 
by EMSA in vitro, it would be beneficial to check for TrxG binding to short 
RNA, as it has been shown that the lncRNA HOTTIP can can target proteins of 
the trithorax complex to the HOXA locus (Wang et al., 2011). Our laboratory 
has tested for sense-strand short RNA, and it is possible that the RNA that 
binds to TrxG is rather anti-sense strand (Herzog et al., 2014). 
 
 
Search for other possible short RNA function and interactions: 
13.  Binding of PRC1 to polycomb target genes is not directly dependent on 
H3K27 methylation by PRC2 (Blackledge et al., 2014). Moreover, the CBX7 
subunit of PRC1 has  an RNA binding domain (Bernstein et al., 2006a) and 
has been shown to bind the ncRNA ANRIL (Yap et al., 2010). EMSAs and 
RNA IP could reveal whether this domain also binds short RNA at polycomb 
target genes. 	 ﾠ 117	 ﾠ
14.  shRNA-medicated knockdown of short RNAs was not found to 
be  efficient  (Russell  Bouwman  and  Richard  Jenner,  personal 
communication). Thus other methods would be needed to assess the 
functionality of the short RNAs. It would be possible to transfect into 
MSCs a YY1pLuc vector with a single mutation that disrupt the short 
RNA stem-loop and then create a compensatory mutation somewhere 
else  that  restores  the  RNA  structure  and  where  the  DNA  is  still 
mutated. 
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Annexes 
 
Table 2: List of primers used for amplification in different experiments. 
 
 
 
Table 3: Northern blotting probes used for detection of short RNAs in murine 
ES cells, and human CEM, PBMCs and SH-SY5Y cell lines. 
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Table 4: Northern blotting probes spanning the HOXD11.12 PRE. 
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